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Executive Summary
The purpose of this project was to improve patient clinical outcomes of average
length of stay, mortality rate, and readmission within 30 days by increasing health care
provider order set usage and documentation as it relates to patients with a primary 
diagnosis of Chronic Obstructive Pulmonary Disease (COPD). Epic ™ computer based 
clinical documentation by healthcare providers at The Christ Hospital (TCH) was 
inconsistent. The PICOT question developed was: in the COPD population of an acute
care hospital, how does standardized electronic COPD process measure documentation 
and order set usage compared to no COPD process measure documentation and order set
usage effect patient outcome measures, within a two month timeframe? The Evidence
Based Practice Improvement Model was used to guide the project. The evidence base for 
the documentation improvement in the project was the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) guidelines. Two opportunities to improve the
documentation were the COPD exacerbation order sets and a Respiratory Therapy (RT)
COPD assessment. The COPD Exacerbation order set for health care providers included
a general information section, consults, nursing orders, respiratory orders, and 
medications. Specific orders were pre-checked, giving the healthcare provider an 
opportunity to check or uncheck any individual order in each section depending on the 
individual patient. The RT COPD assessment consists of six categories for 
documentation: 1) baseline activity, 2) COPD Assessment Test (CAT™), 3) Spirometry 
Classification, 4) COPD exacerbations, and 5) COPD diagnostics, and 6) COPD Inhaled 
Therapy Score. Tests of change included creating, implementing, re-vising, and re-
educating the COPD exacerbation order set usage and the RT COPD assessment standard 
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documentation flow sheet in Epic ™ production. Both documentation improvement
opportunities were placed into Epic ™ Production. 
A total of 151 acute care admissions (ACA) were reviewed from November 1, 2014 
through January 31, 2015. The COPD exacerbation order set usage and documentation 
compliance reached the desired outcome of 50% week five. The best single week for 
COPD exacerbation order set usage at 66.7% week thirteen. The RT COPD assessment
documentation exceeded the desired outcome of 100% week fourteen. The clinical
outcomes data varied from November 2013 to January 2014. The ALOS varied from 5.91 
days in November decreasing to 4.56 days in December and 5.84 days in January. 
Mortality rate varied from 3.03 in November decreasing to 0.00 in December and 1.35 in 
January. The percent of COPD patients readmitted within 30 days was 18.75 in 
November decreasing to 11.54 in December, and 15.07 in January. All three clinical
outcome measures for the same comparable quarter timeframe: ALOS, mortality rate, and 
readmission with 30 days decreased. ALOS decreased from 5.08 for Oct – Dec 2013 to 
4.98 for Oct – Dec 2014 (a decrease of 0.1). Mortality rate decreased from 1.77 for Oct –
Dec 2013 to 1.63 Oct – Dec 2014 (a 0.14 decrease). Readmission within 30 days
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INTRODUCTION
This project utilized the Evidence Based Practice Improvement (EBPI) model
(Figure 1) to improve standardized documentation and order set usage of patients with 
COPD in an acute care setting (Levin, Keffer, Marren, Vetter, Lauder, & Sobolewski, 
2010). The EBPI model includes seven steps (I-VII) that were used to develop and guide
the project. Implementing the evidence-based standard COPD measures and the order 
sets into an electronic medical record allowed for simple and rapid change to achieve the
desired patient outcomes. As stated by Levin, et al, “the systematic-one step at a time-
approach helps avoid organization-wide implementation of practices that are based on 
little, poor, or no evidence” (Levin, et al., 2010, p. 124). Since the evidence base practice
















Evidence-Based Practice Improvement Model
Reprinted with permission (Appendix A).
I. DESCRIBE THE PROBLEM
Chronic lower respiratory disease, primarily chronic obstructive pulmonary disease
(COPD) was the third leading cause of death in the United States in 2011 (Hoyert & Xu, 
2012) and projected by the Global Burden of Disease Study to be the third leading cause
of death worldwide by 2020 (Vestbo, et al., 2013). Fifteen million Americans have been 
diagnosed with COPD (Centers for Disease Control and Prevention, 2011). The age-




















Control and Prevention, 2011). Survival rate for patients was 72% at one year, 52% at
two years, and 26% at five years post discharge (Chung, Winship, Phung, Lake, &
Waterer, 2010). According to the Global Initiative for Chronic Obstructive Lung Disease
(GOLD) guidelines, COPD is a common yet preventable and treatable disease
characterized by persistent airflow limitation. COPD is usually progressive and 
associated with an enhanced chronic inflammatory response in the airways and the lung 
to noxious particles or gases. Exacerbations and comorbidities contribute to the overall
severity in individual patients (Vestbo, et al., 2013). COPD includes emphysema, chronic
bronchitis, and in some cases asthma (Centers for Disease Control and Prevention, 
2013a). Complex chronic diseases, such as these, require multi-level inter-professional
management.
Disease management can be examined using the construct of “quality measures”. 
Quality measures are mechanisms that enable the user to quantify the quality of a selected 
aspect of care by comparing it to an evidence-based criterion that specifies, which is 
better quality (Agency for Healthcare Research and Quality, 2014). Two distinct types of
quality measures are process measures and outcome measures. A process measure is
defined as a process of care in a health care-related activity performed for or on behalf of
a patient (Agency for Healthcare Research and Quality, 2014). Process measures are
supported by evidence that the clinical process or the focus of the measure has led to 
improved outcomes. These measures are generally calculated using the total number of
patients eligible for a particular service in the denominator, and the total number of
patients who either do or do not receive the service in the numerator (Agency for 





















    
chronic stable coronary artery disease (CAD) who were prescribed lipid-lowering 
therapy.  An outcome measure of care is a health state of a patient resulting from the
delivery of health care. Outcome measures are supported by evidence that the measure
has been used to detect the impact of one or more clinical interventions. Measures in this
domain are attributable to antecedent health care and should include provisions for risk-
adjustment (Agency for Healthcare Research and Quality, 2014). The clinical outcome
measures chosen for this study are 1) average length of stay, 2) mortality rate, and 3) 
readmission within 30 days. These measures can focus attention on a broad set of
healthcare activities that affect patients’ well-being. 
Health care providers can use the COPD quality measures if documented 
appropriately to enhance patient care outcomes. However, poor health care provider 
clinical documentation and poor decision support tools such as order sets as it relates to 
COPD hinder those treatment plans. Quality measures for chronic obstructive pulmonary 
disease (COPD) had not been captured in the electronic health record (EHR) at The
Christ Hospital (TCH) a large Midwestern acute care hospital. 
Significance
Although reimbursement for hospitals is an incentive to choose the quality measures
such as process measures and clinical outcome measures, quality and patient safety 
should be the reward. The prevalence of COPD is clearly a significant health problem by 
nation, state and local regions statistics. The national prevalence of COPD was 11.76%, 
and for Ohio 13.63%, and Hamilton County, Ohio it was 10.31%. This represents the
percent of Medicare fee-for-service beneficiaries who have COPD (Hamilton County, 









        
  




   
   
 
   




Hamilton County, by fiscal year (July 1 – June 30), was as follows: FY 2013: 474, and 
FY 2014: 489. This represented an increase of 15 discharged patients in a two year 
timeframe. For the timeframe of the study November, December, and January for 
2013/2014 there were a total of 138 discharged patients and for November, December, 
and January 2014/2015 there were a total of 159 discharged patients with a primary 
diagnosis of COPD. This is an increase of 21 patients over the three months of the
previous year.
The prevalence of COPD is higher in smokers and former smokers than in those that
have never smoked. Risk factors for COPD include exposure to tobacco smoke, 
occupational dust, vapors, and fumes, indoor air pollutants such as coal, straw, crop 
residues, and wood used to fuel homes, outdoor air pollutants, aging, lung infections, 
asthma, and gender (Mannino & Buist, 2007). Common co-morbid conditions that occur
with COPD include cardiac disease such as congestive heart failure (CHF), diabetes
mellitus, hypertension, osteoporosis, and psychological disorders. These are commonly 
reported in patients with COPD however there is great variability in prevalence (Chatila, 
Thomashow, Minai, Criner, & Make 2008;Vestbo, et al., 2013). Patients with COPD may 
have one or more of these co-morbid conditions making it difficult to treat the underlying 
COPD. Accurate information documented electronically is essential to the diagnosis and 
treatment of all disease conditions. 
Mortality continues to increase particularly among African Americans with COPD. 
Although this increase may be related to changing smoking habits, some studies suggest
that African Americans may be more susceptible to tobacco smoke than whites






   
       
  
   
  
 
     
 
 
       
  
  
   
  
 
published data on racial and ethnic disparities in disease outcomes, such information is
notably lacking in the COPD literature (Dransfield & Bailey, 2006). Mortality rates for 
the leading causes of death are generally declining; however, relative differences between 
racial/ethnic groups are not declining (Keppel, Pearcy, & Heron 2010).
Approximately 20% of patients hospitalized for COPD exacerbations in the United 
States will be readmitted within 30 days. Recently the Centers for Medicare and
Medicaid Services revised the Hospital Readmissions Reduction Program and established 
financial penalties to hospitals with high all-cause 30-day re-hospitalization rates after a
hospitalization for COPD exacerbation on or after October 1, 2014 (Prieto-Centurion, et 
al., 2014). The Christ Hospital estimates a potential loss of 1.5 million dollars without
successful readmission prevention.
Cost
The Hospital Inpatient Quality Reporting (Hospital IQR) program was originally 
mandated by Section 501(b) of the Medicare Prescription Drug, Improvement, and 
Modernization Act (MMA) of 2003 (Centers for Medicare and Medicaid Services, 
2013b). This particular section authorized CMS to provide higher payment to hospitals
who successfully report designated quality measures. The Deficit Reduction Act of 2005 
increased the amount to 2.0 percentage points (Centers for Medicare and Medicaid 
Services, 2013b). In addition to providing hospitals a financial incentive to report the
quality services, CMS receives hospital data to help consumers make informed decisions
about health care. Some of this hospital quality of care information has been available to 




         
    
   
    
    
 
   
 
   




   
    
    
 
  
     
Both the clinical and economic burden of COPD are significant and increasing 
(Blanchette, Gross, & Altman, 2014). Providing treatment to patients with COPD in the
emergency department (ED) or hospital accounts for significant portion of total COPD
costs (Stanford, Shen, & McLaughlin, 2006).  Patients presenting to the hospital in a
decompensated state consume costly and expensive resources. In October 2014, CMS
expanded its hospital readmission reduction program (HRRP) to include COPD
(Feemster & Au, 2014) and hence will no longer provide payment if a patient is
readmitted within 30 days of prior admission. 
Practice of Electronic Health Record
Quality measures can be monitored using the electronic health record (EHR) as this
should lead to more efficient, safer, and higher-quality care, however, there are no 
reliable estimates of the practice of adoption of electronic health records in United States
hospitals (Jha, DesRoches, Campbell, Donelan, Rao, Ferris, & Blumenthal, 2009). 
According to the Office of the National Coordinator (ONC) for Health Information 
Technology, an EHR is “designed to reach out beyond the health organization that
originally collects and compiles information. They are built to share information with 
other health care providers, such as laboratories and specialists, so they contain 
information from all the clinicians involved in the patient’s care (HIMSS, 2011).” ONC 
defines an electronic medical record as “a digital version of the paper charts in the
clinician’s office. An EMR contains the medical and treatment history of the patients in 
one practice. … But the information in EMRs doesn’t travel easily out of the practice

















        




variable. Although each discipline agrees to use the EHR 100% of the time, the quality of
the use of the record is yet to be determined. 
For more than 10 years, Cleveland Clinic Providers have used a shared electronic
medical record (EMR) for all outpatient visits spanning the hospital-based practice
facilities (Rimmerman, 2014). They implemented a uniform EMR outpatient template
that included uniform note structure, enhanced content, documentation of risk-based 
decision-making, documentation of patient complexity and acuity, and documenting 
(Rimmerman, 2014). The content was standardized to 13 sections including chief
complaint, history of present illness, past medical, surgical, family and social history, 
medications, and a data section. More than 75% of the physicians have been trained and 
are using the new note template. This strategy further advanced patient care as it
incorporated risk-based billing and the unanticipated benefit of enhanced revenue
(Rimmerman, 2014). The ability to communicate with patients, sharing testing results in 
a secure and expedient electronic manner (Rimmerman, 2014). Findings from the study 
shared emphasized the incomplete documentation and the complexity of decision-
making.  
The decision-making environment is uncertain and may change while decisions are
being made, goals may be shifting, ill-defined or competing (Higgs, Jones, Loftus, &
Christensen, 2008). Decision making occurs in the form of action-feedback loops, where
actions result in effects and generate further information that decision makers have to 
react to and use in order to make further decisions (Higgs, et al., 2008). Decisions contain 
elements of time, pressure, and personal stress and have significant outcomes for the




















influence decision making (Higgs, et al., 2008). With these multiple factors that influence
decision making putting a process in place to standardize clinical documentation may 
assist to ease the decision making process. By having the standard documentation 
available to the practitioners at the time of decision making, the practitioner is better 
informed of the patient’s condition at that point in time. 
II. FORMULATE FOCUSED CLINICAL QUESTION
PICOT Question
After identifying a clinical problem, the second step a key step in the evidence-based 
practice improvement model is to formulate a focused clinical question. Formulating a
clinical question in a systematic way, makes it possible to find an answer quickly and 
efficiently, leading to improved processes and patient outcomes (Stillwell, Fineout-
Overholt, Melnyk, & Williamson, 2010). The PICOT question is a consistent, systematic
way to identify the components of a clinical issue (Stillwell, et al., 2010). PICOT is an 
acronym for the elements of the clinical question: patient population (P), intervention or 
issue of interest (I), comparison intervention or issue of interest (C), outcome of interest
(O), and time it takes for the intervention to achieve the outcome (T) (Stillwell, et al., 
2010). For the study, the following focused clinical PICOT question was developed. In 
the COPD population of an acute care hospital (P), how does standardized electronic
COPD process measure documentation and order set usage (I) compared to no COPD
process measure documentation and order set usage (C) effect patient outcome measures, 










































         
  




PICOT Question for COPD Documentation
Format Specific clinical question Rationale for selection of the specific
component component
P In the COPD population of
an acute care hospital
I how does standardized 
electronic COPD process
measure documentation and 
order set usage
C compared to no COPD
process measure
documentation and order set
usage
O effect patient outcome
measures
T within a two month 
timeframe
Acute care admissions for COPD exacerbation 
have been increasing over the last three years at
The Christ Hospital.
RT COPD Assessment and COPD exacerbation 
order set were electronically built in Epic ™
based on the GOLD guidelines of evidence-
based practice.
Prior to November 1, 2014 the documentation 
efforts have not existed. 
Clinical trials and observational studies suggest
that several aspects of care provided to patients
hospitalized for exacerbations of COPD can 
have significant effects on patient outcomes
such as average length of stay, mortality rate, 
and percent readmit within 30 days (Centers for 
Medicare and Medicaid Services, 2013).
Focused timeframe chosen for implementation 
as a census representation of the population at
The Christ Hospital.
III. SEARCH FOR EVIDENCE
The third step of the framework was to search for evidence to answer this
intervention PICOT question. This requires substantiated cause and effect relationships
(Melnyk and Fineout-Overholt, 2011, p. 32). The different levels of evidence include
Level I evidence from a systematic review or meta-analysis of all relevant randomized 
control trials (RCT) to Level VII evidence from the opinion of authorities and or reports





   
   
  
  






       
 
 
PICOT question there were four Level I systematic reviews. Both systematic reviews and 
meta-analyses yield the strongest level of evidence to base practice decisions (Melnyk 
and Fineout-Overholt, 2011). Several methods were used to search for evidence. The goal
was to find one or more theoretical frameworks to guide the project and complete a 
literature search to support the PICOT question. The frameworks chosen were the
Evidence Based Practice Improvement Model and Kotter’s Eight Step Model for 
Organizational Change were selected for the project. 
As part of the first step in a literature search to support the PICOT question, key 
words were identified. The key words for this search included chronic obstructive
pulmonary disease (COPD), COPD measure, COPD performance, COPD, electronic, 
electronic medical record (EMR) and COPD, electronic health record (EHR) and COPD, 
COPD and acute care, and standardized electronic documentation. Exclusion criteria
were used standardizing dictation, implementing EMR, EMR dictation, EMR templates, 
health information systems, dictation versus templates, copying, pasting, and duplication. 
Using the PICOT question an evidence review for initiating practice change was
completed. 
The vocabulary was controlled due to the fact that COPD is such a broad subject. 
Initial searches of just the words chronic obstructive pulmonary disease (COPD) totaled 
more than 62,000 hits. Google Scholar alone yielded 27,600 articles. COPD measure had 
1,424 results. COPD performance had one result. COPD and electronic had one result. 
The results for electronic medical record (EMR) and COPD were 12. The results for 
electronic health record (EHR) and COPD had nine hits. COPD and acute care had 258 






        




        
  












databases that were searched included the Cochrane Database of Scientific Review, 
CINAHL, PsychINFO, MEDLINE with Full Text, and Google Scholar.
A clinical practice guideline search was done using the U.S Department of Health 
and Human Services, Agency for Healthcare Research and Quality, National Guideline
Clearinghouse (U.S. Department of Health and Human Services, n.d.c). During this
search two additional guidelines were discovered for COPD.
IV. APPRAISE AND SYNTHESIZE EVIDENCE
The fourth step of the EBPI model is to appraise and synthesize the evidence. The
types of tools used to complete the appraisal and synthesis were; 1) inclusion and 
exclusion criteria; 2) a rapid critical appraisal of clinical practice guidelines; 3) a rapid 
critical appraisal of systematic reviews; 4) an evaluation and synthesis of the evidence. 
This included a synthesis table of level and quality of the articles and a comparison of
variables of interest across studies table.
Inclusion/Exclusion Criteria
An initial evaluation of the evidence was completed using inclusion and exclusion 
criteria. To be included or excluded in the project similar characteristics of studies were
analyzed. Inclusion criteria consisted of the relevance of a COPD strategy, readmission 
and mortality outcome goals, guideline implementation, assessments for COPD, and a
cost aspect of COPD. The rationale for exclusion includes articles that may have an 
outpatient, ambulatory, pulmonary rehabilitation, physician office, template, or an EMR 
implementation focus. There were a total of 44 articles from the initial search chosen. Of





            
 
 





   
 
 
          







Rapid Critical Appraisal of Clinical Practice Guidelines
The COPD guidelines found from the search were reviewed. A quick review was
also done on the websites using “Selected Guideline Databases” of Melnyk and Fineout-
Overholt (2011). Utilizing the search function on the U.S Department of Health and 
Human Services, Agency for Healthcare Research and Quality, National Guideline
Clearinghouse, COPD was entered into the search box. There were 11 guidelines for this
topic. To narrow the review COPD was quickly located that included the words chronic, 
stable, and the diagnosis and management of COPD. Three guidelines met the criteria: 
National Guideline Clearinghouse (NGC)-8641, Diagnosis and management of stable
chronic obstructive pulmonary disease, NGC-7966 Chronic Obstructive Pulmonary 
Disease, and NGC-9466 Chronic Obstructive Pulmonary Disease. The results were then
filtered by years 2007-2013. No results were found for 2008, 2009, or 2012. Guidelines
related to nursing care, dyspnea, vital signs, work loss, pulmonary rehabilitation, asthma, 
allergy, immunology or long-term care were eliminated due to project specific goals of
clinical documentation and patient outcomes. 
Guidelines were analyzed using the guideline comparison tool and the guideline
summary (U.S. Department of Health and Human Services. (n.d.a.), U.S. Department of
Health and Human Services. (n.d.b.) One result was found for each year 2007, 2010, and 
2011 that was applicable to this project. During the literature search two additional
guidelines were discovered: the NICE guideline and one the GOLD guideline. These
were be included in the appraisal process. The specific results of the Rapid Critical









   
   
 
    
 
   
        





          
 
 
All five guidelines met credibility standards as in the guidelines were developed by
representatives who were key stakeholders in the specialty and interdisciplinary. The
guideline NGC: 8641 was developed by the Minnesota Evidence-based Practice Center 
and included inter-societal stakeholders. This guideline was excluded due to the age of
the guideline being from 2007.The NGC: 7966 guideline was developed by The
University of Michigan Health System however they were only an internal stakeholder 
within their system with funding by the University of Michigan Faculty. The NICE
guideline was developed by the National Collaborating Centre for Acute and Chronic
Conditions. This guideline was excluded because the recommendations were not tagged 
by the level or strength of evidence upon which it is based and linked with the scientific
evidence according to the rapid critical appraisal checklist. NGC: 9466 developed by 
Medical Services Commission, British Columbia was excluded because the decision 
making process was not to indicate if discussed, sensible, or impartial. 
The GOLD guidelines met all of the criteria from the rapid critical appraisal checklist
and were extensively evaluated globally by world-wide stakeholders with updates as 
recent as 2013. (Vestbo, et al., 2013). Objectives of the GOLD guidelines were to not
only increase awareness of disease prevalence and also summarize and recommend 
treatment strategies to achieve effective COPD management (Gronkiewicz & Borkgren-
Okonek, 2004). This guideline is included to guide the project.
Rapid Critical Appraisal of Systematic Review
Four systematic reviews were found and of the Level I that yield the strongest level
of evidence. There was one review that was identified for COPD (Halbert, Natoli, Gano, 
















    




         
 
 
information technology has on quality, efficiency, and cost of medical care (Chaudhry, 
Wang, Wu, Maglione, Mojica, Roth, & Shekelle, 2006), and two identified for computer-
based clinical decision support systems on physician/practitioner performance on patient
outcomes based on a literature review search (Garg, et al., 2005; Hunt, Haynes, Hanna, &
Smith, 1998). All systematic reviews were analyzed using the “Rapid Critical Appraisal
Checklist for Systematic Reviews of Clinical Intervention Studies” (Melnyk & Fineout-
Overholt, 2011, p. 516). 
The aim of the first systematic review was to quantify the global prevalence of
COPD by means of a random effects meta-analysis (Halbert, et al., 2006). A PubMed 
search was conducted for population-based prevalence estimates published during 1990-
2004. Of 67 accepted articles, 62 unique entries yielded 101 overall prevalence estimates
from 28 different countries. Halbert and colleagues concluded that although prevalence
estimates for COPD are published for many areas of the world there is a lack of for key 
regions around the globe. Overall the critical appraisal analysis of this systematic review
revealed that the results are valid and will assist in improving quality of care for the
COPD patients at The Christ Hospital (TCH). The results were precise and the
confidence interval was 95% (Halbert, et al., 2006). Therefore this systematic review is a
review worth using in this project.
The two systematic reviews were identified for computer-based clinical decision 
support systems on physician/practitioner performance on patient outcomes. The first
review (Hunt, et al., 1998) examined the effects of computer-based clinical decision 
support systems on physician performance and patient outcomes. This review involved 






   
   
  






       
 
 
library, Inspec and SciSearch from 1974 – 1992 for studies limited to the English 
language. A total of 68 studies were included and used terms such as computer-assisted 
decision making, computer-assisted diagnosis, computer-assisted diagnosis, computer-
assisted therapy, and hospital information systems (Hunt, et al., 1998). A linear 
regression of the validity scores of all trials in the review against the year of publication 
showed that study quality increased significantly over time (CI- 0.07-0.20) (Hunt, et
al.,1998). The conclusion of the review was that published studies of computer based 
clinical decision support systems are increasing rapidly and their quality is improving 
(Hunt, et al.,1998). This review supports the utilization of the EMR and decision support
systems affect healthcare provider clinical documentation performance and patient
outcomes.
The second review (Garg, Adhikari, McDonald, Rosas-Arellano, Devereaux, 
Beyene, & Haynes, 2005) examined the effects of computerized clinical decision support
systems on practitioner performance and patient outcomes. The objective was to review
randomized and nonrandomized controlled trials. One hundred studies met their inclusion 
criteria. The review had a confidence interval of 0.73-0.88. This review concluded that
the effects of clinical decision support systems improve practitioner performance. The
effects on patient outcomes remain understudied and, when studied, inconsistent (Garg, 
2005).
One final review examined the impact of health information technology on quality, 
efficiency, and costs of medical care (Chaudhry, et al., 2006). The authors systematically 
searched English literature in MEDLINE from 1995-2004, the Cochrane Central Register 









        





   
         
  
 
    
   
Periodical Abstracts Database. This review included descriptive and comparative studies
and systematic reviews of health information technology. There were 257 studies that
met the inclusion criteria. The authors concluded that four benchmark institutions
demonstrated the efficacy of health information technologies in improving quality and 
efficiency (Chaudhry, et al., 2006). 
Evaluation of the Evidence
In addition to evidence provided by guidelines and systematic reviews, another tool
used to evaluate the evidence is the “evaluation table”. The only studies put in the table
are the studies that address the project question after the rapid critical appraisal was
completed (Melnyk & Fineout-Overholt, 2011, p. 320). It reviews other formats that must
be evaluated and uses the following criteria: citation, framework/design, setting/sample, 
variables and their definitions, outcome measure, data analysis, findings, and appraisal
worth to practice (Melnyk & Fineout-Overholt, 2011). The six studies in the evaluation 
table (Appendix C) all have strengths and weaknesses. 
The first study was a retrospective medical record review examining long-term
trends related to readmission and survival following hospitalization for COPD (Geelhoed, 
Brameld, Holman, & Thompson, 2007). There were 47,439 total admissions of which 
22,686 were COPD and 29,816 were asthma patients. The outcomes that were measured 
were morbidity, mortality, and readmission. A Cox regression analysis revealed that age
(P, 0.0001), sex (p< 0.0001) and International Classification of Diseases (ICD) 
subcategory for COPD (P,0.0001) showed independent effects on the risk of death. The
strengths of the study design include data analyzed across 19 years of admissions














       
 
 




version 10. Predictive variables were evaluated for their effect on survival using Kaplan-
Meier analysis. Variable categories were compared and tested for statistical significance
using the log-rank test. The influence of multiple variables on survival was tested using 
the Cox proportional hazards regression model. The potential weaknesses of the study
include lack of discussion and a limited results section. This study supports the use of
length of stay, mortality rate, and readmission as clinical outcome measures. 
The second study was a prospective cohort study of mortality after hospitalization of
COPD in an acute care hospital in Barcelona, Spain, includes a sample size of 135 
consecutive patients hospitalized after exacerbation of COPD. The design determined a
group of COPD patients who were at risk for experiencing mortality. The objective was
to identify variables associated with mortality in patients admitted to the hospital for 
acute exacerbation of COPD (Almagro, et al., 2002). The outcome measures were
mortality at 180 days, 1 year, and 2 years, and length of stay (Almagro, et al., 2002). 
Other measures in the study included qualitative variables such as mean length of
stay, respiratory failure, bronchodilators, mechanical ventilation, patient’s dead at the end 
of the study, and mortality (Almagro, et al., 2002). This study supports the process
measure of bronchodilators and the clinical outcome measures of length of stay and 
mortality.      
A survey of one hundred participating hospitals was designed to assess the general
organization of COPD care and how that relates to specific indicators (Stone, Harrison, 
Lowe, Buckingham, Pursey, Hosker, & Roberts, 2009). The survey questions were
grouped into five main areas. They are organizational aspects of COPD service such as






   
  




        
 








BTS/NICE COPD management guidelines, non-invasive ventilation (NIV), pulmonary 
rehabilitation, early discharge schemes, and oxygen service (Stone, et al., 2009). The
outcome measures and findings of the survey were as follows:
• 76% had written local guidelines
• 77% have a specialist respiratory ward 
• 59% include specialty triage
• 84% have a formal pulmonary rehab
• 63% have access to early discharge scheme
• 95% have the availability of acute non-invasive ventilation (NIV)=95% 
The use of the written guidelines, acute non-invasive ventilation (NIV), and smoking 
cessation education supported their use in this project from a process measure and order 
set perspective.
Retrospective chart audit data was collected on the management of 1400 cases of
acute care admissions with COPD in thirty eight United Kingdom (UK) hospitals
(Roberts, et al., 2001). It examined evidence of using standards of care and the
management of COPD in the hospital setting. A comparative analysis was performed on 
the data collected for continuing management and discharge between those cared for by 
respiratory specialist physicians and non-specialist physicians. P-values from Chi-
squared tests of significance and 95% confidence intervals (CI) for the difference
between group percentages were calculated. Respiratory specialists were more likely to 
record FEV1 recorded (Chi-squared 127.4 with a p-value <0.001), chart peak expiratory 
flow (PEF) (Chi-squared 35.8 with a p-value <0.001), check inhaler technique, give







   
   
 
 









medications at discharge such as home nebulizers (Chi-squared 43.1 with a p-value
<0.001), and arrange follow-up (Chi-squared 0.06 with a p-value <0.001) (Roberts, et al., 
2001). Sixty-six percent of the patients had a previous admission for COPD, forced 
expiratory volume (FEV1) only found in 53% of the cases, arterial blood gas (ABG) were
done on 79% of the cases, O2 was only prescribed in 64% of the cases, there were, and 
inhalers were used 91% of the time (Roberts, et al., 2001). This study supports the efforts
of standard clinical documentation. This study measures process of care against national
guidelines for the management of COPD (Roberts, et al., 2001). This study supports the
use of guidelines and bronchodialators as part of the COPD inhaled therapy score process
measure documentation by the respiratory specialists.
A multicenter, cross-sectional, retrospective study predicted length of stay of older 
patients with exacerbated chronic obstructive pulmonary disease (Incalzi, Pedone, Oncer, 
Pahor, & Carbonin, 2001). The sample included 3789 patients. The outcome measures
were mortality rate and length of stay. On admission, patients underwent a structured 
assessment of demographic data, nutritional status, cognitive and physical functions, 
comorbidity, and pharmacological therapy in the two weeks prior to admission. Variables
univariately distinguishing groups were entered into a logistics regression analysis having 
long-stay as the dependent variable (Incalzi, et al., 2001). Living alone (Odds Ratio (OR) 
1.33, 95% Confidence Limits (CL)), use of more than 3 drugs prior to admission (OR 
1.29, CL 1.09-1.51), use of drugs with respiratory depressant properties prior to 
admission (OR 1.24, CL 1.05-1.46), and the presence of more than 3 comorbid diseases
(OR 1.88, CL 1.61-2.19) were independent correlates of long-stay. The results suggest





   
 
 
         
   
 












of a long length of stay (Incalzi, et al., 2001). This study identified the hospitalized 
COPD patients that on the day of admission and by capturing identified documentation in 
the EHR, one can predict length of stay in the COPD identified patient population which 
correlates to this project.
One final article was a retrospective cohort descriptive study of 1098 patients who 
died in 2004 with a cause of death of COPD or lung cancer (Goodridge, et al., 2008). The
underlying cause of death was lung cancer in 483 patients, COPD in 615, and both lung 
cancer and COPD in 63 patients (Goodridge, et al., 2008). Those 615 with COPD were
more likely to have more than one co-morbid condition. The study identified that there is
an increase in health care utilization in the 12 months prior to death with the median 
average length of stay of 5.71 days (Goodridge, et al., 2008). By doing this research the
article concludes that health care utilization of patients with COPD and lung cancer in the
last 12 months of life is predictable and measurable. By using other resources such as
long term care, home health, and palliative care to fill gaps in service these may affect
health care utilization including the acute care length of stay.
Synthesis of the Evidence
A synthesis table of level and quality of the articles was completed as adapted from
Melnyk and Fineout-Overholt, 2011. One article (Almagro, et al., 2002) is a level II 
which is a well-designed randomized control trial (RCT). This means that the majority of
the evidence is systematic and the meta-analysis is relevant. The quality of the evidence
was high with strong design, strong findings, and minor weaknesses or flaws. Three
articles were a level III i.e. a well-designed controlled trial without randomization 






   
 
   
     
   



















   
   
   
   
  
      
  
 
     
         
   
     
 
  
      
 
  
      
 
 
    
 
      
 
  
    
 
   
  
      
  
 
     
  
      
 






        
 
   
 
 
high quality and one was of medium quality. One article was level IV with quality high 
and one was level VI with medium quality (Incalzi, et al., 2000). Overall the articles
support the process measures that were gathered during a multidimensional assessment. 
This includes demographic data, health-related habits, nutritional status, body mass
index, lab levels, mental status, physical activity, pharmacological therapy and the
clinical outcome measures of readmission, length of stay, and mortality. Table 2 is the
synthesis table of level and quality of the evidence.
Table 2

























Almagro, et al., (2002) Mortality
after hospitalization of COPD X X
Stone, et al., (2009) Introducing
the national COPD resources
and outcomes project
X X
Roberts, et al., (2001) Audit of
acute admissions of COPD:
standards of care and
management in the hospital
setting
X X
Incalzi, et al., (2000) Predicting




Goodridge, et al., (2008) Health
care utilization of patients with
COPD and lung cancer in the
last 12 months of life
X X
(adapted from Melnyk & Fineout-Overholt, 2011)
The final step is comparison of variables of interest across studies, Table 3. From the
appraisal and synthesis of this evidence there is sufficient evidence at this time to support
the process and outcome variables. From a process standpoint baseline activity, COPD
exacerbation classification, COPD diagnostics, and COPD inhaled therapy score was
strongly supported in the literature with COPD assessment (CAT™) and Spirometry 






   
   


















            
  
            
  
            
  
            
   
          
  
   
         
  
            
   
            
  
            
 
 






          
were discussed as important variables. With the amount of evidence available on the
topic of COPD gaps in knowledge related to the clinical problem was not identified. 
Table 3
Comparison of Variable of Interest across Studies

























al. (2007) X X
Siafakas, et
al., (1995) X X X X X X
Almagro, et




(2009) X X X X X
Goodridge, et
al., (2008) X X
Roberts, et
al., (2001) X X X X X X X
Incalzi, et
al., (2000) X X X X X X
Sonstein, et
al., (2014) X X X
(adapted from Melnyk & Fineout-Overholt, 2011)
V. DEVELOP AIM (GOAL) STATEMENT
The fifth step of the EBPI model is to develop goal or aim statements. The Institute for 
Healthcare Improvement has developed five tips for setting aims that includes: 1) state
the aim clearly (make sure the aim statement describes the system to be improved, 2) 
include numerical goals that require fundamental change to the system (clarifies the
numeric aim and create tension for change),  3) set stretch goals that are done within a
certain time, 4) avoid aim drift (once aim set, the team must not drift), 5) be prepared to 
refocus on the aim (review and re-review as needed) (Institute for Healthcare
Improvement, 2012). 
The first aim was to improve clinical documentation of process measures categories
that include: 1) Baseline Activity, 2) COPD Assessment Test (CAT™), 3) Spirometry 





   
         
         
 
 
   
       






Therapy Score and COPD exacerbation order set usage in 50% of patients with a primary 
diagnosis of COPD in a two month timeframe. Appendix D is a sample complete
documentation of the measures called RT COPD Assessment using fictitious information.       
The second aim was to improve clinical outcomes. Clinical trials and observational
studies suggest that several aspects of care provided to patients hospitalized for 
exacerbations of COPD can have significant effects on mortality, thus supporting the
essential construct of mortality as an appropriate outcome to measure quality (Centers for 
Medicare and Medicaid Services, 2013). The outcome measures for this project were 1) 
average length of stay, 2) mortality rate, and 3) readmission within 30 days.  The
definitions for all measures are in two tables to maintain consistency and standardization.  
Table 4 includes the COPD process measure definitions and Table 5 includes the COPD





COPD Process Measure Definitions 
Measure NQF# Measure Steward Description Numerator Denominator Exclusions 
Title Statement 
Baseline CDC General physical activities Mild: 0-2.9 METS No Exclusions 
Activity American College defined by level of Moderate: 3.0-6.0 
of Sports Medicine intensity: METS 
Mild Vigorous: > 6.0 
Moderate 
Vi!rnrous 
COPD 0577 National Committee The percentage of patients At least one Anyone 42 years Patients from the denominator if they had 
Assess-ment for Quality 40 years of age and older claim/encounter for or older as of an outpatient visit, an observation visit, and 
Test (CAT) Assurance with a new diagnosis of spirometry during the December 31 of ED visit, or an acute inpatient encounter 
COPD or newly active 73 0 days (2 years) tbe measurement during the 730 days (2 years) prior to the 
COPD, who received prior to the Index year, who had a index episode start date, with a diagnosis of 
appropriate spirometry Episode Start date diagnosis of COPD COPD, emphysema, or chronic bronchitis. 
testing to confirm the through 180 days (6 during the Intake For an inpatient Index Episode Start Date, 
diagnosis months) after the Period. use the data of admission to determine this 
Index Episode Start exclusion. 
Date 
Spirometry 0091 American Medical Percentage of patients Patients with All patients aged Exceptions include medical reason(s) or 
Classificat- Association - aged 18 years and older documented 18 years and older patient reason(s) for the patient not 
ion Physician with a dia,,onosis of COPD spirometry results in with a diagnosis of documenting spirometry results 
Consortium for who had spirometry tbe medical record COPD 
Performance results documented (FEVl and 
Improvement FEVI/FVC) 
(AMA-PCP I) 
COPD GOLD guidelines Visits within 1 year for the Total visits for All visits 
Exacerbat- following: COPD within 1 year 




3. Primary Care Visits 
COPD GOLD guidelines On a scale of 1-4 Breath sounds 
Inhaled Dyspnea (SOB) 
Therapy Bronchodialator 















        
   
  
    
   
 
         














VI. PLAN, DO, STUDY, ACT CYCLES
 
The sixth step in the EBPI model was to perform the Plan, Do, Study, Act (PDSA) 
cycles for improvement. PDSA is the scientific method adapted for action-oriented 
learning (Institute for Healthcare Improvement, 2012).The PDSA cycle guides the test of
a change to determine if the change was an improvement (Institute for Healthcare
Improvement, 2014). The Plan-Do-Study-Act (PDSA) cycle is shorthand for testing a
change in the real work setting — by planning it (P), trying it (D), observing the results
(S), and acting on what is learned (A).       
Agency permission for conducting the doctoral project was obtained from The Christ
Hospital (Appendix F). Permission was granted by the Chief Medical Officer that
allowed the agency to be identified in the final report. The project received institutional
review board (IRB) approval from both Wright State University (Appendix G-1) and The
Christ Hospital (Appendix G-2).
Kotter’s Eight Step Model for Organizational Change
The Kotter’s eight step model for organizational change was used to assist with the





   
  
   
    
              
                    
      
        
    
    
    
          
            
      
       
 
            




           
 
       





           
   
Table 6
Kotter Eight Steps to Change Management
8 Steps to Change Management
Change Stage Description
1 Create Urgency Help the team see the need for change and theimportance of speed
2 Create a Coalition Ensure to have support from top levels with theright skills and credibility to drive change
3 Develop a Vision &Strategy
Leverage the evidence for change to create a
shared roadmap and success metrics
4 Communicate theVision
Confirm acceptance and understanding
5 Empower Action Remove barriers to make the team successful
6 Get Quick Wins Identify and broadcast early wins to maintainmomentum
7 Leverage Wins toDrive Change
Use momentum from quick wins to continue
driving change
8 Embed in Culture Reward and encourage new behaviors to embedinto the culture
Source: Kotter International, 2014
Kotter has conducted research on change using this model over years that follow “The 8-
Step Process for Leading Change” that help organizations succeed in an ever-changing 
world (Kotter International, 2012; Mbamalu & Whiteman, 2014).
Evaluation Plan
The effectiveness of the plans was evaluated using four software systems: Epic™, 
Midas +™, SAP Crystal Reports™, and Microsoft Excel™. 
Epic ™ makes electronic healthcare software for mid-size and large medical groups, 
hospitals and integrated healthcare organizations – working with customers that include
community hospitals, academic facilities, children's organizations, safety net providers
and multi-hospital systems (Epic ™, 2014). This software contains all clinical
documentation data that is entered for each patient by the healthcare provider. Epic™ is
where the order set and the RT COPD assessment were documented.
The Midas+™ software is a quality-driven software solution used in the acute care





   
 
         
 
 
   
 








          
 
 
    
   
performance management needs” (Midas +, 2015). Epic™ has a one way interface with 
Midas+™ that permits data flow between software programs. Midas+™ was used to 
analyze the clinical outcome data for the patients that had a primary diagnosis of COPD
exacerbation. 
SAP Crystal Reports™ is a software product that transforms data from Epic™ into
standard reporting. With this system, one can create powerful, richly formatted, dynamic
reports from virtually any data source (SAP Crystal Reports, n.d.). This software permits
the clinical data Epic™ to be used for reporting. The SAP Crystal Reports™ was used 
determine if the order set was used.
Microsoft Excel™ performs complex analyses and summarizes data with previews of
pivot-table options, so one can compare them and select data that tells the story best
(Office, 2015). The Epic™ clinical documentation flow was analyzed using a
“Documentation data collection tool” built in Microsoft Excel™ (Appendix H). It was
called “Order Set Usage Report” with the primary diagnosis of COPD and was the order 
set used yes or no (Appendix I). There were a total of 151 acute care admissions (ACA) 
that were included in this report. To evaluate the effectiveness of order set usage a
Microsoft Excel™ report was run weekly. 
The entire process includes a Crystal Report that identifies the patients with the
Order Sets used in Epic™. Then a report is run in Midas +™ of those patients with a
primary diagnosis of COPD. Both reports are then imported into Microsoft Excel™ and a 
comparison is done with both sets of data to determine which patients did or did not have
the order set used. Percentage used was then calculated weekly until the 50% goal was






   










   
 
 
        
   
 
per 1000 Acute Care Admits was used. The measure description is the frequency of
encounters with a principal diagnosis of COPD per 1,000 acute care inpatient encounters
(Midas + DataVision and CPMS™, 2014). Once the patients were identified, the list was
sent to the medical record department where the records were placed in an Epic™ kiosk 
for a review of the RT COPD assessment completion. All of these software programs
help supply data for analysis.
PDSA Cycle 1
The aim of the first PDSA cycle for improvement (Appendix J-1) was to create a 
sense of urgency by helping the team see the need for change and the importance of
speed as stated by Kotter. This PDSA cycle was to also create the COPD exacerbation 
order set (Appendix E) and RT COPD Assessment (Appendix D) based on the GOLD
guidelines. The COPD exacerbation order set included the following sections: general
information such as the display name, synonyms, description that includes the GOLD
guideline, web information, consults such as pulmonary disease, palliative care, nutrition, 
pulmonary rehabilitation, and case manager, nursing orders, respiratory orders, and 
medications. The RT COPD assessment included the following categories: 1) Baseline
Activity, 2) COPD Assessment Test (CAT™), 3) Spirometry Classification, and 4) 
COPD diagnostics, and 5) COPD Inhaled Therapy Score. 
The first test of change was to create the order set and the RT COPD assessment in 
the Epic ™ EHR. An order set is a preconfigured group of orders that are commonly 
ordered together for a specific problem (Epic ™, 2010, p. 143). A flow sheet is a




















   
  
known as documentation flow (Epic ™, 2010 p.90). The RT COPD assessment is a flow
sheet. This is the optimal system to assist with the COPD project.
PLAN. The plan includes a list of the tasks that are needed to set up the test of
change. There were eight steps that include:
1.	 Create a sense of urgency (Kotter’s step 1).
2.	 Create a coalition (Kotter’s step 2) using the multidisciplinary team that included 
information technology (IT), physicians (internal medicine and pulmonologists), 
respiratory therapy, nursing, dietary, case management, and pharmacy. 
3.	 Develop a vision and strategy (Kotter’s step 3) and create the COPD exacerbation 
order set and the RT COPD assessment. 
4.	 Communicate a vision and strategy (Kotter’s step 4) and meet with the following 
committee: IT, physicians (internal medicine and pulmonologists), respiratory 
therapy, nursing, dietary, case management, and pharmacy to determine the content
of the order set.
5.	 Build the order set and the RT COPD assessment in the playground based on 
committee feedback. This was done by the IT department.
6.	 Test the order set and the RT COPD assessment by the above committee to ensure
accuracy.
7.	 Empower action (Kotter’s step 5) and collaborate/coordinate with the chief nursing 
officer (CNO), director of pharmacy and the medical executive committee (MEC) to 







         
   
     









   
    
  
8. Educate IT, physicians (residents, internal medicine and pulmonologists), respiratory 
therapy, nursing, nurse practitioners, dietary, case management, and pharmacy 
(Appendix E and Appendix D).
DO. What actually happened when the test was carried out was that the COPD
exacerbation order set and RT COPD assessment were created by the multidisciplinary 
team with suggested content from the GOLD guidelines. IT then built the
recommendations electronically into Epic™. The next step was that the COPD
exacerbation order set was tested and validated by healthcare providers. This was done in 
Epic™ pre-production which is an area to practice what was built. Two health care
providers and two respiratory therapists tested and validated that the COPD exacerbation 
order set and RT COPD assessment standard documentation to ensure its accuracy. To 
test and validate the COPD exacerbation order set three fictitious patients were admitted 
to the electronic medical record with a primary diagnosis of COPD. The health care
providers placed the COPD exacerbation order set for each patient. All consults were
checked to validate the flow of the consult to the designated discipline such as pulmonary 
disease, palliative care, nutrition, pulmonary rehabilitation, and case management. Each 
discipline then validated the receipt of the consult. This was also done with nursing, 
respiratory, and medication orders. To test and validate the RT COPD assessment two 
respiratory therapists documented on the fictitious patients and then validated the others
data entry for accuracy. This was done in August of 2014. Final approval of the COPD
exacerbation order set and the RT COPD assessment was then done by CNO, director of
pharmacy and the MEC in August of 2014. Education of IT, physicians (all residents, 






       
    
    
 
        









            
  
  




dietary, case management, and pharmacy was completed in September 2014 by 
respiratory therapy and the quality director in multiple venues.
STUDY. The study part of the PDSA cycle is to describe the measured results and 
how they compared to the predictions. The measured results were that the COPD
exacerbation order set and the RT COPD assessment were successfully built in Epic™
and validated for accuracy by the appropriate disciplines.
ACT. The act part of the cycle was to describe what modifications to the plan were
made for the next cycle from what was learned. Next step was to place the COPD
exacerbation order set and the RT COPD assessment into Epic™ live production by IT to 
be used with the primary diagnosis of COPD exacerbation on November 1, 2014. This
lead to PDSA cycle 2 to implement what was created in PDSA cycle 1. 
PDSA Cycle 2
The aim of the second PDSA cycle for improvement (Appendix J-2) was to 
implement the project by placing the COPD exacerbation order set and the RT COPD
assessment into Epic™ live production and to begin using them both with the patients
with a primary diagnosis of COPD exacerbation on November 1, 2014. 
PLAN. The plan includes a list of the tasks that are needed to set up the test of
change. There were four steps that include:
1.	 Place Epic ™ order set template and documentation flow build from the playground 
into Epic ™ live production on November 1, 2014. This was done by IT.
2.	 Remind nurses, nurse practitioners, respiratory therapists, physicians, physician 








     




            
   
   
    
   
  
  
             
 
 
   
   
 
3.	 Evaluate COPD the order set usage and documentation effort with the use of a data
collection tool weekly. This was done by the clinical data center, the quality 
director/student, and the respiratory therapy nurse manager.
4.	 Continue PDSA cycle until >50%
The next step of the plan was to predict what will happen when the test was carried 
out and measure to determine if the prediction succeeds. The prediction was that order set
usage and the RT COPD Assessment documentation will increase to at least 50% in the
two month timeframe based on a weekly data collection report and the medical record 
analysis.
DO. The next step in the PDSA cycle is to implement the plan. The COPD
exacerbation order set and the RT COPD documentation was implemented in Epic™ live
production by IT to be used as soon as a patient with the primary diagnosis of COPD was
admitted to the acute care setting. There were reminders sent by email to nurses, nurse
practitioners, respiratory therapists, physicians, and physician assistants that both would 
be available for use on November 1, 2014 by the quality director/student. Data analysis
was evaluated on November 7, 2014 by the clinical data center, the quality 
director/student, and the respiratory therapy nurse manager.
STUDY. The study part of the PDSA cycle in this project was to describe the
measured results and how they compared to the predictions. The order set usage (n=1) 
analysis for project week one was zero percent and the RT COPD assessment was also 
zero (n=1). It was identified during this step that the COPD-GOLD guideline





          
    
 
 
         
 




   









     
ACT. The act part of the cycle is to describe what modifications to the plan will be
made for the next cycle from what was learned. The next cycle of improvement was to 
add COPD-GOLD guidelines classification to the RT COPD Assessment and provider re-
education.
PDSA Cycle 3
The aim of the third PDSA cycle for improvement (Appendix J-3) is to add COPD-
GOLD guideline classification to the RT COPD assessment documentation flow and to 
once again attempt to increase the score to 50%. It was identified within the first week of
implementation of PDSA cycle 2 that the GOLD guideline classification was accidently 
omitted. Again, it was added as number four of the RT COPD assessment (Appendix D). 
This test of change was to implement the improved standard documentation flow
template that now includes the classification. 
PLAN. The list of tasks that needed to be set up for this test of change was as 
follows:
1.	 Educate respiratory therapy on the addition of the GOLD guideline classification
that included an email reminder from the quality director/student.
2.	 Place Epic ™ documentation flow build from the playground into Epic ™ live
production was done by IT.
3.	 Evaluate COPD documentation effort with the use of a data collection tool weekly 
until documentation is >50% by the clinical data center, the quality 
director/student, and the respiratory therapy nurse manager.








    
   
 
          
  
  
    
 
 
   
   
          
 
 
   
 
           
   
 
DO. The next step in the PDSA cycle is to implement the plan. Education of
respiratory therapy about the addition of the GOLD guideline classification was done
with an email reminder. The COPD GOLD guideline classification was added to the RT
COPD Assessment in Epic™ production in collaboration with IT. Testing was completed 
in Epic™ pre-production by one respiratory therapist. Finally, the GOLD guideline
classification was then placed in Epic™ production and an evaluation of the
documentation efforts was completed.
STUDY. The respiratory therapy department began to document the COPD
guideline classification in Epic ™ week two. The percentage of COPD exacerbation 
order set usage both week two and three was 40% (n=10) and RT COPD Assessment
documentation for week two was 20% (n=5) and week three was 40% (n=5). To leverage
this quick win (Kotter’s step 6) and to leverage this win to drive change (Kotter’s step 7) 
this momentum was used to continue to drive change. At this point it was identified 
during this cycle that education of both the COPD exacerbation order set usage and the
RT COPD documentation needed to occur.
ACT. The act part of the cycle is to describe what modifications to the plan will be
made for the next cycle from what was learned. Based on the results of the first three
weeks of the project it was identified that re-education of the healthcare providers needed 
to occur leading to the fourth PDSA cycle.
PDSA Cycle 4
The aim of the fourth PDSA cycle for improvement (Appendix J-4) was healthcare
provider re-education about the COPD exacerbation order set usage and the RT COPD






           
 
   
 
     
    
   










   
 
usage and the RT COPD Assessment documentation based on reports run by the clinical
data center and the medical record analysis. It was identified that healthcare provider re-
education needed to occur and so was developed.
PLAN. The comprehensive detailed re-education plan that was developed was as 
follows:
1.	 Continue to conduct data analysis of order set usage and RT COPD assessment
documentation
2.	 Review literature, speak with multiple stakeholders to determine the best way to 
communicate the order set to the healthcare staff and to increase documentation 
efforts there was an evaluation of multiple education strategies. There were
several education strategies implemented. “Strategies for Healthcare Education”
promotes evidence-based teaching that provides a thorough, critical analysis of
various healthcare teaching strategies, offering new strategies and an integrative
approach promoting blended learning (Woodhouse, 2007). By using multiple
methods it allowed for variation in learning. The learning chosen included a
multi-faceted approach such as face-to-face, hand held devices such as “smart
phones, laptops, and tablets”, email, and lecture using a presentation method. 
3.	 Discuss order set usage with the following physicians, family medicine, internal
medicine, gerontology, hospitalists, and allied health professionals including 
nurse practitioners to reinforce the importance of using evidence based practice
and to increase their usage.
4.	 Communicate the vision (Kotter’s step 4) and develop and share the following 




    
 
   
    
 
 
    
    
  
  
   
  
  
     
   
 





a.	 A flyer to be displayed in the Medical Staff lounge that includes the
contents of the COPD exacerbation order set, the GOLD guidelines
reference, who to use the order set with, and who to call if there are any 
questions about the order set (Appendix K).
b.	 A presentation to be used at the Service Line quality meetings that include
the medical director, business director and the clinical director (Appendix
L).
c.	 An assessment form for the respiratory therapy department explaining the
specific contents of the RT COPD Assessment (Appendix M).
d.	 A presentation to educate the respiratory therapy department and nursing 
(Appendix N).
e.	 A work list in Epic ™ for the respiratory therapy department to identify 
the patients concurrently in the acute care setting. Appendix O is an 
example using fictitious information.
5.	 Communicate fallout reports weekly on Fridays with the healthcare providers
beginning at the end of each week (Appendix P). These reports were sent to the
chief medical officer, service line leaders, and respiratory therapy so they can 
encourage those healthcare providers to use the COPD exacerbation order set.
Do. The next step is to do the plan. This included continuing to conduct data
analysis and communicate fallouts percentage by email weekly. The literature was 
reviewed for education strategies. Then multiple education materials were developed and 
shared with IT, physicians (residents, internal medicine and pulmonologists), respiratory 





              
 
   
  
          
 
 














approximately 1200 health care providers. The learning chosen included a multi-faceted 
approach such as face-to-face, hand held devices such as “smart phones, laptops, and 
tablets”, email, and lecture using a presentation method.  
Study. The goal of the study was to increase the order set usage on a weekly basis to 
50% (n=12, total n=23) in a two month timeframe actually was accomplished in four 
weeks. The RT COPD assessment documentation was 50% in week five of the project
(n=6, total n=29). 
Act. There were no further PDSA cycles as the order set usage and RT COPD
assessment documentation goal was met. Data was collected and analyzed until January 
31, 2015 to ensure a representative sample from which the findings are generalizable. To 
embed into the culture (Kotter’s step 8) at The Christ Hospital and to reward and 
encourage the new processes a basket of fruit and candy was sent to celebrate their 
success.
There was an initial idea to integrate evidence-based practice into standardized 
documentation. To support an iterative approach, one must establish a “learning loop”
(Langley, Moen, Nolan, Nolan, Norman, & Provost, 2009, p. 103). Figure 2 depicts that
learning loop called repeated PDSA cycles to test change. There were a total of four 
PDSA cycles for improvement, weekly data analysis, refinement leading to the next


















Repeated PDSA Cycles to Test a Change
(Adapted from The Improvement Guide, 2009)
VII. DISSEMINATE BEST PRACTICE
The final step of the EBPI framework is to disseminate best practice and the outcome
of the project. After the data are gathered and analyzed, it’s time to share what has been 
learned (Fineout-Overholt, Gallagher-Ford, Mazurek, Melnyk, & Stillwell, 2011). 
Another technique for organizational change and learning is called “Framework for 
Spread”. This framework was identified by members of the Veterans Health 
Administration in collaboration with the Institute for Healthcare Improvement (IHI) 
(Nolan, Schall, Erb, & Nolan, 2005). The Framework for Spread identifies the following 
components for planning the spread of new ideas:
1.	 The responsibilities of leadership: leaders set the agenda for change through 
aligned goals, multifunctional steering committee to lead the spread effort, and a













         
 
  
     
 
 
    
 
 
2.	 Identification of better ideas: the benefit to all adopters relative to other ideas.
3.	 Communication: once better ideas are documented and successful other sites
identified, leaders initiate the set-up for spread by identifying the target the other 
sites through communication techniques. Communication is the heart of spread.
4.	 Strengthening the social system
5.	 Measurement and feedback: measurement is the integral part of improvement. It
provides information about whether the changes made in a system are having the
desired effect. 
6.	 Knowledge management: as ideas are adapted to a local level and then spread, 
adopters generate knowledge about the ideas and how best to improve outcomes. 
Leaders need to capture this knowledge and make it available to others on an 
ongoing basis. 
The dissemination can be done both inside the organization and outside. Inside the
project can expand to not only primary diagnosis of COPD, but also a secondary 
diagnosis of COPD, to complete COPD management across the continuum of care. The
project can be disseminated with other Epic ™ and Midas+ users in Cincinnati and all
Epic ™ users. It can be shared at their annual Epic ™ user group meeting through a
presentation, workshops and publishing articles. Midas + data are compared within the
database against other Midas + users. Best practice is shared with those users. By using 
this type of framework it would allow spreading the change from local improvement to 



















       
   
 
   
  
VIII. OUTCOMES OF PROJECT
 
Presentation of Findings
The COPD exacerbation order set and the RT COPD assessment were created in 
Epic™ the month of August 2014 with approval from the Chief Nursing Officer, 
Pharmacy, and the Medical Executive Committee. The education for the project occurred 
throughout the month of October 2014 in preparation for go-live scheduled for November 
1, 2014. Education was provided for IT, physicians, respiratory therapy, nursing, dietary, 
case management, and pharmacy. The COPD exacerbation order set and the RT COPD
assessment was place in Epic™ on November 1, 2014. The evaluation of the project was
conducted from November 1, 2014 to March 6, 2015 to ensure final data for readmissions
and mortality rate were available. 
Process Measures Findings
Week one of the project yielded a zero percent usage rate for both the COPD 
exacerbation order set and the RT COPD assessment. There was only one patient
discharged that had a primary diagnosis of COPD. Although the COPD-GOLD 
guidelines classification had been omitted from the RT COPD Assessment, it was added 
within the first week and provider re-education occurred. The data was analyzed weekly 
to determine opportunities for improvement. 
Order Set Usage. The data for COPD exacerbation order set usage was analyzed 
weekly. The COPD exacerbation order set usage week two and three of the project was 
40%. The fourth PDSA cycle for improvement of health care provider re-education 
occurred and yielded a 50% order set usage week five. The individual project weeks one, 




















COPD exacerbation for those weeks were one, three, and one respectively. Overall
cumulative COPD exacerbation order set usage for the fourteen weeks average was
48.34% for those discharged patients with a primary diagnosis of COPD exacerbation. 
Project week fourteen yielded one opportunity to use the COPD exacerbation order set
that didn’t occur for a zero percent usage. Figure 3 depicts order set usage from
November 1, 2014 through January 31, 2015 with the PDSA cycles for improvement
identified.
Figure 3
















RT COPD Assessment. The RT COPD assessment documentation for week one also 
yielded a zero percent. By week two documentation compliance had increased to 20% 
and by week three was 40%. Documentation compliance reached 50% by week five. 
Although there was a slow start a steady increase trend occurred over the fourteen week 
timeframe. Education of three more respiratory therapists and a nurse manager occurred 









     
                  
 
 
            
 




    
  











assessment documentation compliance reached 42.38% for those discharged patients with 
a primary diagnosis of COPD exacerbation. Figure 4 depicts RT COPD Documentation 
from November 1, 2014 through January 31, 2015 with the PDSA cycles for 
improvement identified. 
Figure 4
RT COPD Assessment Documentation – November 2014 - January 2015
Project Week
Outcome Measure Findings
Midas + ™ was used to analyze the four outcome measures COPD rate per 1000 
acute care admissions (ACA), average length of stay (ALOS), mortality rate, and percent
readmit within 30 days. The outcome measures for calendar year (CY) 2013 and 2014 are
presented in Table 7. The data is also depicted by month for CY 2014. November, 
December, and January 2014 saw a steady increase in COPD patients per 1000 ACA. 
ALOS varied from 5.91 days in November decreasing to 4.56 days in December and 5.84 
days in January. Mortality rate varied from 3.03 in November decreasing to 0.00 in 
December and 1.35 in January. The percent of COPD patients readmitted within 30 days






         
 
       
    
     
    
  
 





             
 
Table 7
Clinical Outcome Measure Data-Calendar Year and by month



























COPD -­‐ Per 1000 ACA 26.29 27.72 45.57 33.97 29.11 30.81 20.08 21.90 16.82 22.86 31.38 24.53 22.97 31.69 46.54 
COPD -­‐ ALOS 5.52 5.61 6.67 5.88 6.07 5.75 5.16 6.94 4.58 5.81 4.55 4.74 5.91 4.56 5.84 
COPD -­‐ Mortality Rate 2.02 1.43 2.86 0.00 0.00 2.27 0.00 3.13 0.00 3.13 0.00 2.63 3.03 0.00 1.35 
COPD -­‐ Readmit within 30 Days 15.29 16.74 19.12 16.67 16.28 11.63 25.81 16.13 8.33 22.58 20.46 13.51 18.75 11.54 15.07 
Note. Midas+ DataVision and CPMS, 2015
The outcome measure data for (CY) 2013 and (CY) 2014 was also analyzed by 
quarter (three month blocks; Table 8) to compare October (Oct), November (Nov), and 
December (Dec) of both years. COPD per 1000 ACA had increased from Oct – Dec 2013 
from 25.16 and Oct - Dec 2014 was 26.58. This is an increase of COPD diagnosis by 
1.42 per 1000 ACA. All three clinical outcome measures for the same comparable quarter 
timeframe: ALOS, mortality rate, and readmission with 30 days decreased. ALOS
decreased from 5.08 for Oct – Dec 2013 to 4.98 for Oct – Dec 2014 (a decrease of 0.1). 
Figure 5 depicts the average length of stay by quarter among acute care patients
diagnosed with COPD exacerbation.
Figure 5

















            
 
    








Mortality rate decreased from 1.77 for Oct – Dec 2013 to 1.63 Oct – Dec 2014 (a 0.14 
decrease). Figure 6 depicts the mortality rate by quarter among acute care admission with 
a primary diagnosis of COPD.
Figure 6












Readmission within 30 days decreased from 14.41 for Oct – Dec 2013 to 14.05 for Oct –
Dec 2014 (a 0.14 decrease). Figure 7 depicts the percent of readmissions within 30 days
by quarter. These patients are the percent of patients with a non-elective readmission to 

















       
 
    
Figure 7






Table 8 is the actual data by quarter. This data is from calendar year 2013 and calendar 
year 2014. 
Table 8


















COPD -­‐ Per 1000ACA 31.87 25.58 22.68 25.16 36.38 24.14 23.65 26.58 
COPD -­‐ ALOS 6.03 5.26 5.60 5.08 6.27 5.94 4.96 4.98 
COPD -­‐ Mortality Rate 2.70 1.61 1.84 1.77 1.24 1.87 1.00 1.63 
COPD -­‐ % Readmit within 30Days 13.89 16.39 16.82 14.41 17.61 17.14 18.18 14.05 
Note. Midas+ DataVision and CPMS, 2015
IX. DISCUSSION
Interpretation of Findings
The use of Kotter’s “Eight Steps to Change Management” assisted The Christ
Hospital to embrace the evidence-base practice change in the treatment of the COPD






     
 
      
 
    
 
   
 
  
   
Hospital. Each step is identified on the left with corresponding change that occurred on 
the right that ultimately lead to the new behavior that is embedded into the culture. 
Figure 8
The Eight Step to Change Management at The Christ Hospital
The purpose of this project was to improve patient clinical outcomes by improving 
health care provider COPD exacerbation order set usage and RT COPD assessment
standardized documentation as it relates to patients with a primary diagnosis of COPD. 
The aims of the project were to increase documentation for at least 50% COPD patients
over a two month time frame for the COPD exacerbation order set and RT COPD
assessment. The documentation of the COPD exacerbation order set usage increased to 
50% by week four of the project and the RT COPD assessment increased to 50% by week 
five. The best single week for order set usage was 66.7% week thirteen. The best week 










   
  
  
   
 
            
 





discussed, the clinical outcomes data varied from November 2013 to January 2014. All
three clinical outcome measures for the same comparable quarter timeframe of 2013:
ALOS, mortality rate, and readmission with 30 days decreased.
The strength of the project is the ability to incorporate evidence-based practice into 
the COPD exacerbation order set and RT COPD assessment to guide clinical practice that
required collaboration of multiple disciplines. The use of order sets has been identified as
one method of standardizing care and improving outcomes for specific patient
populations (Best, et al., 2011). A comparable study concluded that the use of
standardized asthma assessment and management protocols enables many of the clinical
problems associated with the treatment of asthma in hospital emergency departments to 
be overcome (Chouald, el al., 2004). By standardizing and increasing the compliance of
the RT COPD assessment documentation efforts the treatment of COPD was enhanced 
based on better clinical information available to the treating health care providers. 
This project was implemented in November 2014 with compliance of the order set
usage and RT COPD Assessment documentation attained within a five week timeframe
which did not leave enough time to demonstrate improved clinical outcome measures.
The COPD exacerbation order set usage and the RT COPD assessment standard 
documentation of 50% was attained in a very short period of time. COPD exacerbation 
order set usage increased to 50% by week four. The best single week for order set usage
was 66.7% week thirteen. RT COPD Assessment increased to 50% by week five. 
The best week for RT COPD assessment documentation was 100% week fourteen. This
required reinforcing positive outcomes and opportunities for improvement on a weekly 






          
  
   
 
 








         
  
   
    
    
   
set and RT COPD assessment to guide clinical practice required collaboration of multiple
disciplines. There is a tentative early effect on the clinical outcomes that would benefit
from further study.
The project included implementing evidence based research across multiple
disciplines to improve care provided to the COPD patient. The project identified multiple
additional opportunities such as increasing knowledge of COPD exacerbation and the
GOLD guidelines for physicians, residents, nursing, respiratory therapy, and allied health 
professionals such as nurse practitioners and physician assistants. 
Information technology capability was identified such as best practice alerts that can 
occur as soon as the COPD diagnosis is entered into the EMR to prompt the order set
usage this was not built into the plan. This capability was not identified by information 
technology (IT) during the planning cycle. 
The project also identified education opportunities such as the GOLD guideline
application for quick reference on a computer or smart phone. Successful innovation in 
telehealth requires an understanding of patient physiology and psychology (Tarassenko, 
et al., 2013). This application can be used by healthcare providers to maintain evidence
based practice as it becomes available at their fingertips. 
The evidence based clinical rounds that identify primary diagnosis patients with 
COPD at the point of care can be useful to increase utilization. Patient management
concepts - rather than education - are the primary focus of morning rounds (Giri, et al., 
2013). Integration of the COPD exacerbation order set and RT COPD assessment
conversation into rounds can enhance focus on the management of the patient. Order set 







           
    
   
 
 








        
 
    
  
Software tools that aggregate usage data from EHR systems can help clinicians and 
informatics professionals better manage clinical content and the use of order sets
(Cowansage, Green, Kratz, & Vawdrey, 2012). 
Limitations
Limitations of the project includes that the limited timeframe for the evaluation was 
only three months and implemented during the months of November, December, and 
January. This is the beginning of the cold season which may have caused a seasonal
effect especially since it is only a partial season. COPD patients have been reported to 
experience more frequent exacerbation and increased rate of hospitalization and 
morbidity rates during the winter season (Tseng, Chen, Ou, Hsiao, Li, Wang, & Perng, 
2013). Another limitation is that of sample. The total sample was 151. The Christ
Hospital had 489 patients discharge with a primary diagnosis of COPD in their fiscal year 
from July 1 2013 to June 30 2013. Until there is a complete understanding of their 
management of this disease this is a limitation. The study was also limited to a single
center in a Midwest City. In urban environments, mainly in areas where population and 
traffic density are relatively high, human exposure to hazardous substances is expected to 
be relevant (Nuvolone, et al., 2011). This urban locality may affect the results of the
project. 
X. RECOMMENDATIONS
This project has numerous implications and recommendations for the areas of
nursing practice, nursing administration, and nursing research. The implication for the
nursing practice is that by improving the adherence of the GOLD guidelines for the





















Evidence-based electronic order sets improve compliance with clinical practice
guidelines in patients hospitalized with acute exacerbations of COPD (Sonstein, Clark, 
Seidensticker, Zeng, & Sharma, 2014). The implication for nursing practice is that by not
implementing and staying at the forefront of evidence-based care the patient is the one
who suffers the consequences by not getting the best care they deserve. By teaching 
nurses how to implement evidence-based practice care for all patients can enhance patient
outcomes. Providing research training opportunities to point-of-care clinicians is a
promising strategy for healthcare organizations seeking to promote EBP, empower 
clinicians, and showcase excellence in clinical research (Black, Balneaves, Garossino, 
Puyat, & Hong, 2015). The recommendation is that nurse practitioners get involved in 
assessing and implementing the best evidence for patient care through order set
development.
A clear implication for nursing administration is the cost of care associated with poor
outcome measures: 1) average length of stay, 2) mortality rate, and 3) readmission within 
30 days. According to the Deficit Reduction Act of 2005 the Centers for Medicare and 
Medicaid increased the amount of potential loss to hospitals at an increase of 2.0 
percentage points (Centers for Medicare and Medicaid Services, 2013b). If these quality 
clinical outcome measures are not met it translates into millions of lost revenue. For the
Christ Hospital if the outcome measures are met this revenue could be used for staffing, 
equipment and other valuable resources needed to care for patients. The nurse
administrator puts a structure in place that has refined processes to support the outcomes. 
For average length of stay that is data analysis, discharge planning, flow throughout the






          
    




   
    
 








        
 
appropriate do not resuscitate status, palliative care services, or hospice services. For 
readmission the nurse administrator ensures patient education, post-acute appointments
and services are in place.
The implication for nursing research is the information lacking from the literature of
the advanced practice nurse utilization of order sets. The use of order sets by other health 
care providers such as physicians has been studied from many aspects such as the
implementation of evidence-based order sets, the monitoring of order set usage, and the
systematic update of order sets to improve quality of care (Best, et al., 2011; Cowansage, 
Green, Kratz, & Vawdrey, 2012; & Leau, Morelli, Chung, & Radford, 2013). Poor 
usability is a significant, unanticipated consequence (Zhang, Padman, & Levin, 2013).
The recommendation is that nurse researchers monitor these same aspects of order set
usage.
Based on the outcomes of this evidence-based project, this agency should continue
with the implementation and evaluation for at least one year that crosses the four seasons. 
The documentation of the RT COPD assessment can help with the management of the
patients with COPD so future education on how to utilize this information is
recommended for health care providers. This can be done by using the framework for 
spread discussed previously. In addition the improved documentation should be expanded 
from not just patients with a primary diagnosis but also those with a secondary diagnosis
of COPD. This would be the patients admitted for something other than acute care COPD
exacerbation but is a comorbid medical condition.
The early and accurate diagnosis of COPD was a challenge that could be overcome










     
           
  
    
  
 
   
 
 
             
    
    
    
  
accountability for the usage of the order sets and the RT COPD Assessment
documentation. This would be done by the nurse manager doing audits of the RT COPD
assessment documentation and sharing those audits with the department and the
individual monthly, quarterly, and at annual appraisal with consequences if goals are not
met. This measurement and feedback is an essential part of the dissemination process. It
is the responsibility of the leader of the group to link this structure and process with 
patient outcomes.
The next step of the project is to turn over the process to The Christ Hospital. The
medical staff office and the Chief Medical Officer will ensure the continued use of the
COPD exacerbation order set. The clinical data center will provide the COPD
exacerbation order set report to the medical staff for analysis and performance
improvement. The respiratory therapy department manager will continue to monitor the
RT COPD assessment documentation efforts and assess and plan for opportunities for 
improvement. The quality director will continue to monitor and improve the compliance
of the order set usage and the RT COPD assessment documentation as well as monitor 
the effect of clinical outcome measure data. 
XI. CONCLUSION
To obtain high quality safe care with an impact on clinical outcomes, The Christ
Hospital implemented evidence-based practice by using the Global Initiative for Chronic
Obstructive Lung Disease guidelines and embedding them into clinical practice. This was
done with the use of the Chronic Obstructive Pulmonary Disease exacerbation order set
and the RT COPD assessment. “It is now widely recognized throughout the globe that













the best patient outcomes” (Melnyk & Fineout-Overholt, 2011, p. 1). The evidence-based 
practice improvement model affords a framework to accomplish this task. 
As a chief nursing officer responsible for multiple disciplines one must think of
multiple aspects of healthcare delivery that includes nursing, physicians, therapists, 
information technology, and other. Guideline implementation should address issues
relevant to the interdisciplinary team (Smith, et al., 2005). The advance of the science and 
practice of nursing is best accomplished by a diversity of perspectives with no form of
evidence as subsidiary to another (Baumann, 2010). An old African proverb is that “if





      
         
        
  
         
         
         
 
           
          
  
         
         
 
         
        
  
         
  
         
  
            
        
References
Agency for Healthcare Research and Quality, (May 29,2014), Varieties of measures in 
NCQM, National Quality Measures Clearinghouse. Retrieved from:
http://www.quality measures.ahrq. gov/tutorial/varieties.aspx.
Almagro, P., Calbo, E., de Echagüen, A. O., Barreiro, B., Quintana, S., Heredia, J. L., &
Garau, J. (2002). Mortality after hospitalization for COPD. Chest, 121(5), 1441. 
Baumann, S. (n.d). The limitations of evidenced-based practice. Nursing Science
Quarterly, 23(3), 226-230.
Best, J. T., Frith, K., Anderson, F., Rapp, C. G., Rioux, L., & Ciccarello, C. (2011). 
Implementation of an evidence-based order set to impact initial antibiotic time 
intervals in adult febrile neutropenia. Oncology Nursing Forum, 38(6), 661-668.
Blanchette, C. M., Gross, N. J., & Altman, P. (2014). Rising costs of COPD and the
potential for maintenance therapy to slow the trend. American Health & Drug 
Benefits, 7(2), 98-106.
Centers for Disease Control and Prevention. (2013, November). COPD among adults in 
Ohio. Retrieved from http://www.cdc.gov/copd/maps/docs/pdf/OH_ 
COPDFactSheet.pdf.
Centers for Disease Control and Prevention. (2013a, November). What is COPD?
Retrieved from CDC website http://www.cdc.gov/copd/index.htm.
Centers for Disease Control and Prevention (2011). COPD among adults in Ohio. 
Retrieved from OH_COPDfactsheet.pdf.
Centers for Medicare and Medicaid Services, (2013b). Hospital Inpatient Quality





        
        
            
        
   
        
         
 
         
        
  
        
        
  
         
        
  
         
 
 
         
         
 
HospitalRHQDAPU.html
Chatila, W., Thomashow, B., Minai, O., Criner, G., & Make, B. (2008). 
Comorbidities in chronic obstructive pulmonary disease. Proceedings of The
American Thoracic Society, 5(4), 549-555.
Chaudhry, B., Wang, J., Wu, S., Maglione, M., Mojica, W., Roth, E., & Shekelle, P. 
(2006). Systematic review: impact of health information technology on quality, 
efficiency, and costs of medical care. Annals of Internal Medicine, 144(10), 742-752.
Chouald, C., Bal, J., Fuhrman, C., Housset, B., & Caudron, J. (2004). Standardized 
protocol improves asthma management in emergency department. Journal of 
Asthma, 41(1), 19-25. 
Chung, L. P., Winship, P., Phung, S., Lake, F., & Waterer, G. (2010). Five-year 
outcome in COPD patients after their first episode of acute exacerbation treated with 
non-invasive ventilation. Respirology, 15(7), 1084-1091.
Cowansage, C. B., Green, R. A., Kratz, A., & Vawdrey, D. K. (2012). An application for 
monitoring order set usage in a commercial electronic health record. AMIA
Symposium, 20121184-1190.
Dransfield, M., & Bailey, W. (2006). COPD: Racial disparities in susceptibility, 
treatment, and outcomes. Clinics in Chest Medicine, 27(3), 463-471.
Epic ™, (2014). About us. Retrieved from http://www.Epic ™.com/about-index.php.
Feemster, L., & Au, D. (2014). Penalizing hospitals for chronic obstructive pulmonary 
disease readmissions. American Journal of Respiratory & Critical Care Medicine, 
189(6), 634-639.




        
           
        
 
           
          
          
 
        
         
 
        
        
 
         
          
 
        
         
 
        
         
  
Evidence-based practice, step by step: evaluating and disseminating the impact of an 
evidence-based intervention: show and tell. The American Journal of Nursing, 
111(7), 56-59.
Garg, A. X., Adhikari, N. J., McDonald, H., Rosas-Arellano, M., Devereaux, P. J., 
Beyene, J., & Haynes, R. (2005). Effects of computerized clinical decision support
systems on practitioner performance and patient outcomes: a systematic review. 
JAMA: Journal of the American Medical Association, 293(10), 1223-1238. 
Geelhoed, E., Brameld, K., Holman, C., & Thompson, P. (2007). Readmission and 
survival following hospitalization for chronic obstructive pulmonary disease: long-
term trends. Internal Medicine Journal, 37(2), 87-94.
Giri, J., Ahmed, A., Dong, Y., Keegan, M., Herasevich, V., Gajic, O., & Pickering, B. 
(2013). Daily Intensive Care Unit Rounds: A Multidisciplinary Perspective. Applied 
Medical Informatics, 33(3), 63-73. 
Goodridge, D., Lawson, J., Duggleby, W., Marciniuk, D., Rennie, D., & Stang, M. 
(2008). Health care utilization of patients with chronic obstructive pulmonary disease
and lung cancer in the last 12 months of life. Respiratory Medicine, 102(6), 885-891.
Gronkiewicz, C., & Borkgren-Okonek, M. (2004). Acute exacerbation of COPD: nursing 
application of evidence-based guidelines. Critical Care Nursing Quarterly, 27(4), 
336-352.
Halbert, R., Natoli, J., Gano, A., Badamgarav, E., Buist, A., & Mannino, D. (2006). 
Global burden of COPD: systematic review and meta-analysis. The European 
Respiratory Journal, 28(3), 523-532.




         
  
             
           
        
  
        
  
        
  
         
         
  
        
        
  
          
         
  
          
        
 
         
http://hamiltoncounty.oh.networkofcare.org/ph/indicator.aspx?id=290&c=1.
Higgs, J., Jones, M., Loftus, S. & Christensen, N. (2008). Factors influencing clinical
decision making. Elsevier. Higgs, J. Editor (3rd ed.), Clinical Reasoning in the Health 
Professions. (p.90). Retrieved fromwww.elsevierhealth.com/media/us/sample
chapters/9780750688857/.
HIMSS, (2011). EHR or EMR? Retrieved from
http://www.himss.org/News/NewsDetail.aspx?ItemNumber=6776
Hoyert, D. L., & Xu, J. (2012). Deaths: preliminary data for 2011. National Vital
Statistics Reports, 61(6), 1-51. 
Hunt, D., Haynes, R., Hanna, S., & Smith, K. (1998). Effects of computer-based clinical
decision  support systems on physician performance and patient outcomes: a
systematic review. JAMA 280(15), 1339-1346. 
Incalzi, R., Pedone, C., Onder, G., Pahor, M., & Carbonin, P. (2001). Predicting length of
stay of older patients with exacerbated chronic obstructive pulmonary disease. Aging 
(Milan, Italy), 13(1), 49-57.
Institute for Healthcare Improvement. (2012, October). Science of improvement: Tips for
setting aims. Retrieved from http://www.ihi.org/knowledge/Pages/Howto 
Improve/Scienceof ImprovementTipsforSettingAims.aspx.
Jha, A. K., DesRoches, C. M., Campbell, E. G., Donelan, K., Rao, S. R., Ferris, T. G., &
Blumenthal, D. (2009). Use of Electronic Health Records in U.S. Hospitals. New 
England Journal of Medicine, 360(16), 1628-1638.
Keppel, K. G., Pearcy, J. N., & Heron, M. P. (2010). Is There Progress Toward 




        
     
        
  
         
         
 
        
        
 
         
        
 
         
    
        
        
 
           
        
  
        
 
Health Reports, 125(5), 689-697. 
Kotter International. (2012). The 8-step process for leading change. Retrieved from
http://www.kotterinternational.com/our-principles/changesteps.
Langley, G., Moen, R., Nolan, K., Nolan, T., Norman, C., & Provost, L. (2009). The
Improvement Guide: a practical approach to enhancing organizational performance.
(2nd ed.). San Francisco, CA: Jossey-Bass.
Leu M, Morelli S, Chung O, Radford S. Systematic update of computerized physician 
order entry order sets to improve quality of care: a case study. Pediatrics. March 
2013;131.
Levin, R., Keefer, J., Marren, J., Vetter, M., Lauder, B., & Sobolewski, S. (2010).   
Evidence-based practice improvement: merging 2 paradigms. Journal of Nursing 
Care Quality, 25(2), 117-126.
Mannino, D., & Buist, A. (2007). Global burden of COPD: risk factors, prevalence, and 
future trends. Lancet, 370(9589), 765-773.
Mbamalu, G., & Whiteman, K. (2014). Vascular access team collaboration to decrease
catheter rates in patients on hemodialysis: utilization of Kotter's change process. 
Nephrology Nursing Journal, 41(3), 283-288. 
Melnyk, B. M. & Fineout-Overholt, E. (2011). Evidence-based practice in nursing and      
healthcare: A guide to best practice (2nd ed.). Philadelphia, PA: Lippincott Williams
& Wilkins.
Midas+. (2015). Who we are. Retrieved from
https://www.midasplus.com/pages/AboutUs/AboutUs.aspx.





         
         
      
         
        
         
        
 
  
         
         
        
 
        
  
          
         
         
         
           
        
     
Nolan, K., Schall, M., Erb, F., & Nolan, T. (2005). Using a framework for spread: the
case of patient access in the Veterans Health Administration. Journal on Quality and 
Patient Safety, 32(6), 339-347
Nuvolone, D., della Maggiore, R., Maio, S., Fresco, R., Baldacci, S., Carrozzi, L., &
Viegi, G. (2011). Geographical information system and environmental epidemiology:
a cross-sectional spatial analysis of the effects of traffic-related air pollution on 
population respiratory health. Environmental Health: A Global Access Science
Source, 10(1), 12-23. 
Office. (2015). Excel. Retrieved from https://products.office.com/en-us/Excel.
Prieto-Centurion, V., Markos, M., Ramey, N., Gussin, H., Nyenhuis, S., Joo, M., &
Krishnan, J. (2014). Interventions to reduce rehospitalizations after chronic
obstructive pulmonary disease exacerbations. A systematic review. Annals of the
American Thoracic Society, 11(3), 417-424. 
Rimmerman, C. (2014). Standardizing Electronic Medical Record Documentation. 
Physician Executive, 40(4), 44-48.
Roberts, C., Ryland, I., Lowe, D., Kelly, Y., Bucknall, C., & Pearson, M. (2001). Audit
of acute admissions of COPD: standards of care and management in the hospital
setting. The European Respiratory Journal, 17(3), 343-349.








         
        
  
        
        
 
         
          
  
           
         
 
        
        
 
         
        
   
         
        
  
          
  
Cheok, F. (2005). Barriers to success for an evidence-based guideline for chronic
obstructive pulmonary disease. Chronic Respiratory Disease, 2(3), 121-131. 
Sonstein, L., Clark, C., Seidensticker, S., Zeng, L., & Sharma, G. (2014). Improving 
adherence for management of acute exacerbation of chronic obstructive pulmonary 
disease. American Journal of Medicine, 127(11), 1097-1104. 
Stanford, R., Shen, Y., & McLaughlin, T. (2006). Cost of chronic obstructive pulmonary 
disease in the emergency department and hospital: an analysis of administrative data
from 218 US hospitals. Treatments in Respiratory Medicine, 5(5), 343-349.
Stillwell, S. B., Fineout-Overholt, E., Melnyk, B. M., & Williamson, K. M. (2010). 
Asking the clinical question: a key step in evidence-based practice. American 
Journal of Nursing, 110(3), 58. 
Stone, R., Harrison, B., Lowe, D., Buckingham, R., Pursey, N., Hosker, H., & Roberts, C. 
(2009). Introducing the national COPD resources and outcomes project. BMC 
Health Services Research, 9173.
Tarassenko, L., Velardo, C., Shah, A., Gibson, O., Clifford, G., Heneghan, C., &
Farmer, A. (2013). M-health for long-term management of COPD. International
Journal of Integrated Care (IJIC), 131-2. 
Tseng, C., Chen, Y., Ou, S., Hsiao, Y., Li, S., Wang, S., & Perng, D. (2013). The
Effect of Cold Temperature on Increased Exacerbation of Chronic Obstructive
Pulmonary Disease: A Nationwide Study. Plos ONE, 8(3), 1-7. 
U.S. Department of Health and Human Services. (n.d.a). Guideline comparison. 
Retrieved April 17, 2013, from http://guideline.gov/compare/index.aspx.




          
   
         
         
  
         
        
        
  
               
  
         
         
April 17, 2013, from http://guideline.gov/content.aspx?id=34038.
U.S. Department of Health and Human Services. (n.d.c). National guidelines
clearinghouse. Retrieved April 13, 2013, from http://guideline.gov/browse/by 
topic.aspx.
Vestbo, J., Hurd, S., Agustí, A., Jones, P., Vogelmeier, C., Anzueto, A., & Rodriguez-
Roisin, R. (2013). Global strategy for the diagnosis, management, and prevention of
chronic obstructive pulmonary disease: GOLD executive summary. American 
Journal Of Respiratory And Critical Care Medicine, 187(4), 347-365. 
Woodhouse, J. (2007). Strategies for healthcare education: how to teach in the 21st 
century. Oxon, UK: Radcliffe Publishing Ltd. 
Zhang Y, Padman R, Levin J. Reducing Provider Cognitive Workload in CPOE Use:















Rapid Critical Appraisal Checklist 












NICE Guidelines NGC: 
9466 
I . • - " " , -,,,- , ,, _. ;\i}~F?·t~; · .. · .... ·,_, .. =~·-_: .· .. -..... :·.:~·_:.• . . ,:·. ..• ······ ·· ···•:::>:-:;::<:;.;;: .:::::::>.< .•.• ,.:;.:· .~ .•... :·.· -~t)t~;;;:' i·~:\!/Ci:'.;f.Wff. g:.:m:m;:;{;; •:.: : ... . · " 
1 Who were the The Minnesota University of National Collaborating Medical Services 
guideline Evidence-based Michigan Health Centre for Acute and Commission., 
developers? Practice Center System Chronic Conditions British Columbia 
2 Were the Yes Internal stakeholders Yes Yes 
developers L American College only I. Royal Devon & 1. Medical 
representative of of Physicians 1. Emergency Exeter Hospital Service 
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1. Limitations of 








































Citation Framework/ Setting/ Variables and Outcome Data Analysis FiiJ.dings Appraisal: Worth 
Desim Sample their definitions Measurement to practice 
Goodridge, Retrospective Saskatchewan I.Age Mortality Analysis of UCOD Strengths: 
et al., cohort study Health 2. Sex variance Lung cancer= 1. Statistically 
(2008) administrative 3. Marital Status (ANOV A) with 483 significant 
Health care database 4. Area of Scheffe post- COPD=615 differences for 
utilization 1098 patients Residence hoc tests and x2 Both lung health care 
of patients who died in 5. Co-morbidity tests of cancer and utilization 
witb.COPD 2004 with a 6. Physician proportion COPD=63 2. Decedents with 
and lung cause of death visits When COPD were more 
cancer in ofCOPD 7. Number of assumptions not Statistically likely to be 
the last 12 hospitalizations met the Kruskal significant institutionalized 
months of 8. Length of stay Wallis test differences for for L TC or home 
life (with multiple health care care 
Mann-Whitney utilization 
tests adjusted Weaknesses: 
with Bonferroni 1. Using an 
corrections for administrative 
post-hoc data base 
analysis and 2. Potential 
Fisher's Exact inaccuracy of 
tests used coding 
respectively 3. Lack of 
information 
4. Only one 
Canadian 
province 
5. May have 
regional 
implications 
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Nursing Orders 
ra-Nµr~ng communic.ation ___ ~~---:---:-;·--·---·-·-:-oofrify1E, sfartfngFor.Topcuf(eiiCes _ _ 
- _. _ . .. _ - · . RN t<?. ve!ify ~ patient prior to_ admissioD meds include 
_ .. _ _ _ ·- inhalation medications. if inhalation home meds have 
not been ordered, notify MD. - · .. 
R.l Oxygen therapy 
ra Oxyge!l titration to keep ,Sat~-
-
~ Pulse oximetry 
Respiratory Orders 
Respiratory Therapy 
In BEDSIDE s"?iROMEfRY WITHOUT . 
BRONCl;iQDILATOR - --:_·-=::-: -- _ 
Routine, CONTINUOUS, Starting S 
Device: Nasal Cannula 
Notify and place order for RT if Oxymizer, Venturi 
Mask, Non-Rebreather Mask, or High Flow Nasal 
Cannula is needed and notify physician of increased 
02 requirements. May adjust 02 per titration orsjeJ. _ 
Routine, UNTIL DISCONTINUED, Starting S · 
-Keep SP02: - - -- . - . 
Routine, CONTINUOUS, Starting S 
-~ Routine, ONE TIME,-Starting s For ·1 Occurrences, If 
- :. not in exa.cerbation and if one is not available in the 
- past year.LAST COMPLETED SPIROMETRY .JEST • 
_ IN THE LAST YE.'\R: . @F~OWLAST(?_t~O)@. _.· .::-
.. - - @FLOWLAST(30472093)@. To view spirometry -
_ . --... _ _ .. . _ -· ---- - -~- results go to-chart review >_meclia tab · --=-= · ,-
~ Verify prior to admission inhaled medications Routine, ONE TIME, Starting S For 1 Occurrences 
~ RT COPD Freguency Assessment _ _ Routine, DAILY, Starting S, Adjust inhaled ::. - ·· · -
__ - - · - -- - - ~-· medications per COPD frequency score -
. _ - _ .. _ ( HYPERLINK) ~ · · _ ~ 
ra Assess COPD Frequency Classification Routine, ONE TIME, Starting S For 1 Occurrences, 
~ £?i~tri~ute ta_ke care ~x prior. t9 .<1.ls.c!Jarge 
w; Evaluate for smoking cessation and nicotine 
replacement 
w.J _ Alve_olar Recruitment = -·-=--=- -·~ ·i-: \ ·- -
ra Mucus Clearance 
Medications 
Respiratory Meds and Steroids 
Notify case manager of COPD classification 
Rou!i!I~. Q~_E TIME, Starting S For 1 Qccurrences 
Routine, ONE TIME, Starting S For 1 Occurrences 
~Quttne, EVERY 4 HOURS PRN, Starting S, May · 
initiate_therapy as indicated for alveol~r recruitment 
Routine, EVERY 4 HOURS PRN, Starting S, May 
initi~te ~er~PY. ~ orQer~d (<.?! mucus ..91!laranc~ 
_Routine, DAJL Y, Starting S . .. _ 
ID AL~~TEBQ~ N~B~~IZE~ VIA B·A- N-= --:---------.-----·..-...~-
ffi albuterol (PROVENTIL) nebulizer solution 2.5 mg, Inhalation 
al B_AN (BREA1H _ACT!~f.TED NEBULIZER - ·· · · - Routine, ONE TIME, Starting For 1 Occurrences 
I] DUONEB NEBULIZER VIA BAN --
~
l]l . .:1 .·Afb1_ut~~~l-ll?r~~r-~piU=f!l (DUO~~~) Qe~ul!~~-r_---=._-_-·3-mL, IQhalat~on ! E'{ERY 4 __ Hq.~RS ~ R _ SP so u ion · __ 
Gl BAN (BREATH ACTIVATED NEBULIZER . Routine, EVERY 4 HOURS, Starting 
ni ADVAIR_ 2~0-50.P~.fl!EL .-.- ·-----··---------------------·---·--·~~ 
Jii1 fluticasone-salmeterol (ADVAIR) 250-50 mcg/Puft 
Inhaler 
~ MDJ : 13"I TO_Qp_ ';: 
Advalr 500-50 Panel 
1 Puff, Inhalation, 2 TIMES DAILY - RESP, 
Starting S 
Routine, 2 TIMES DAIL Y1 Starting 
81 
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g fluti~a~one;~al[Tleterol {ADVAIR) 500-50.mcg/Puff .1 Puff, Inhalation, 2 TIMES DAILY - RESP 
inhaler ·- - ·.. -- · ·- · .. -
r:1 MDI .- RT TO DO Routine, 2 TIMES DAILY, Starting 
111 SPIRIVAAND MDI - . - . -· 
Q MDI - RT TO DO -----·----. - --'-"----· -Routin~. DAILY, Starting For Until specified 
{] tiotropium {SPIRIVA) inhalatioru ::apsuJe _ . _ .. 1.Cap, Inhalation. DAILY:. RESP, .Starting S 
111 methylPREDNISolone sod succ {SOLU- 40 mg, Intraven ous, EVERY 8 HOURS 
MEDROL) injection 
r.:J predf1iSON_E (DEL TASONE) tablet - . - -·.:.- _ -.:.- . 40 mg, Oral, DAILY -.. .. ... rn sodium chloride 3 % nebulizer solution 3 ml, Inhalation, 2 TIMES DAILY PRN, Other, mucus 





Restrict SmartSet: rliii 
- -~ 
Settings . -·. _ _ 
Discontinue action: 




Release date: Use System Definitions Setting 





































































Documentation Data Collection Tool




COPD Assessment Test (On	  Scale of 0-­‐5) Yes/No
How often do you cough?
How often do you have phlegm/mucus in your chest?
Does your chest feel tight?
When walking up hill or flight of stairs how breathless
are	  you?
How limited are you at home with activities?
How confident are you in leaving home despite lung
condition?
How soundly do you sleep?
How much energy do you have?
*COPD SCORE	  COMPLETED? Yes/No
COPD Assessment Score
Spirometry Classfication of COPD Yes/No
Spirometry completed within year and available?
Predicted FEV1
Predicted FEV1/FCV ratio less than 0.70?
*SPIROMETRY	  CLASSIFICATION OF	  COPD COMPLETED Yes/No
COPD Exacerbations
Hospitalization Admissions for COPD	  within 1 year
Emergency department for COPD within year
Primary Care	  for COPD within year
Total Visits for COPD within year
COPD Diagnostics Yes/No
Inspiratory Flow Rate Value
*INSPIRATORY	  FLOW RATE	  COMPLETED Yes/No
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Appendix L
Presentation for Healthcare Providers
January 2015 
“Sa e y S a s With Me 
COPD Exacerbation 
& 
Order Set Utilization 
(ID 2076) 
NP / CNS / PA / MD / RN 
COPD 
• Projected by the Global Burden of Disease Study to
be the third leading cause of death worldwide by
2020. 
• The third leading cause of death in the United States 
in 2011. 
• Fifteen million Americans have been diagnosed
with COPD. 
• The age-adjusted percentage of Ohio adults with
COPD in 2011 was 7.1%. 
(Hoyert, et al., 2012)
(Rosisin, et al., 2013) 
(Centers for Disease Control and Prevention, 2011) 
SURVIVAL RATE 
Survival rate for patients was: 
» 72% at one year 
» 52% at 2 years 
» 26% at five years post discharge. 
(Chung, et al., 2010) 
CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
COPD is a common preventable and treatable disease that is
characterized by persistent airflow limitation. It is usually
progressive and associated with an enhanced chronic
inflammatory response in the airways and the lung to noxious 
particles or gases. 
Exacerbations and comorbidities contribute to the overall severity
in individual patients. 
COPD includes emphysema, chronic bronchitis, and in some 
cases asthma. 
(Centers for Disease Control and Prevention, 2013) 
(Roisin, et al., 2013) 
PREVALENCE OF COPD 
National prevalence = 11.76% 
Ohio = 13.63% 
*Hamilton County, Ohio = 10.31% 
The number of patients discharged from The Christ Hospital 
(TCH), located in Hamilton County, by fiscal year (July 1 – 
June 30), was as follows: 
§ FY 2013 = 474 
§ FY 2014: 489 
§ From July 2014 – November 2014 there was a total of 171 patients. 




   
  
   
  




    













• Higher in smokers and former smokers than in those
that have never smoked. 
• The risk factors for COPD include tobacco smoke, 
occupational dust, vapors, and fumes, indoor air
pollutants such as coal, straw, crop residues, and
wood used to fuel homes, outdoor air pollutants, 
aging, lung infections, asthma, and gender. 
(Mannino & Buist, 2007). 
COPD EXACERBATION (ID:2076) ORDER SET 
COPD EXACERBATION (ID:2076) ORDER SET (CONT’D) COPD EXACERBATION (ID:2076) ORDER SET (CONT’D) 
45 PATIENTS W ITHOUT ORDER SET 
1 - AUSTIN,JOE N. 
1 - BERNHEISEL,CHRISTOPHER R. 
1 - BOYLE,SEAN D 
1 - DELAMERCED,AMADOR 
1 - GLASSMAN,A. DANIEL 
1 - LEMING,PHILIP D. 
1 - MAZUR,WOJCIECH 
1 - O'BRIEN,THOMAS 
1 - OKUNADE,MAUSI A. 
1 - PARK,STEVEN E. 
1 - RAWLINGS,DENISHA D. 
1 - STAGAMAN,MARTHA M. 
1 - VEHR,GERALDINE M. 
1 - WEINSTEIN,ERIC J. 
5 - KRIMERMAN,NAUM S. 
4 - DESAI,KALPIN 
4 - BAUMAN,DOUGLAS HAROLD 
2 - STEWART-DEHNER,TERRI L. 
2 - SCOTT,MARK J. 
2 - MOUNT,HILLARY 
2 - LANKA,KIRANMAYEE 
2 - JANSSENS,CHARLES DO 
2 - DAGENBACH,JOSEPH R. 
2 - CHADWELL,CHRISTOPHER L. 
2 - BOLAND,RACHAEL E. 



















10. Expiratory wheezes 
11. Stridor 
12. Tubular 
13. Pleural rub 
14. Other (Comment) 
Breath Sounds L [302410] 1. Clear 
2. Absent 
3. Bowel sounds 





9. lnspiratory wheezes 
10. Expiratory wheezes 
11 . Stridor 
12. Tubular 
13. Pleural rub 
~ 
14. Other (Comment) 
Other Specific Breath Sounds 1. a=Add to flowsheet 
Assessment [250023] 
(C) Breath Sounds: Anterior Lung <Flowsheet Group> 
Fields [250002} 
(C) All Lobes Anterior (250003) 1. AB=Absent 
2. CL=Clear 
3. CR=Crackles 
4 . CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 
9. EEW=End Expiratory Wheezes 
10. IW=lnspiratory Wheezes 
11. PR=Pleural Rub 
12. RA=Rales 
13. RH=Rhonchi 
14. SIR=Sibilant Rhonchi 
15. SOR=Sonorous Rhonchi 
16. ST =Stridorous 
(C) RUL ANTERIOR (250004) 1. AB=Absent 
2. CL=Clear 
3. CR=Crackles 
4. CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 
9. EEW=End Expiratory Wheezes 
10. IW=lnspiratory Wheezes 
11. PR=Pleural Rub 
12. RA=Rales 
13. RH=Rhonchi 
14. SIR=Sibilant Rhonchi 
15. SOR=Sonorous Rhonchi 
16. ST =Stridorous 






4. CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 
9. EEW=End Expiratory Wheezes 
10. IW=lnspiratory Wheezes 
11. PR=Pleural Rub 
12. RA=Rales 
13. RH=Rhonchi 
14. SIR=Sibilant Rhonchi 
15. SOR=Sonorous Rhonchi 
16. ST=Stridorous 
(C) RML ANTERIOR [250006] 1. AB=Absent 
2. CL=Clear 
3. CR=Crackles 
4. CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 
9. EEW=End Expiratory Wheezes 
10. IW=lnspiratory Wheezes 
11. PR=Pleural Rub 
12. RA=Rales 
13. RH =Rhonchi 
14. SIR=Sibilant Rhonchi 
15. SOR=Sonorous Rhonchi 
16. ST=Stridorous -
(C) RLL ANTERIOR (250007] 1. AB=Absent 
2. CL=Clear 
3. CR=Crackles 
4. CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 
9. EEW=End Expiratory Wheezes 
10. IW=lnspiratory Wheezes 
11. PR=Pleural Rub 
12. RA=Rales 
13. RH=Rhonchi 
14. SIR=Sibilant Rhonchi 
15. SOR=Sonorous Rhonchi 
16. ST=Stridorous 
(C) LLL ANTERIOR (250008] 1. AB=Absent 
2. CL=Clear 
3. CR=Crackles 
4. CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 




10. IW=lnspiratory Wheezes 
11. PR=Pleural Rub 
12. RA=Rales 
13. RH=Rhonchi 
14. SIR=Sibilant Rhonchi 
15. SOR=Sonorous Rhonchi 
16. ST=Stridorous 
(C) Breath Sounds: Posterior Lung <Flowsheet Group> 
Fields [250016} 
(C) All Lobes Posterior [250017] 1. AB=Absent 
2. CL=Clear 
3. CR=Crackles 
4. CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 
9. EEW=End Expiratory Wheezes 
10. IW=lnspiratory Wheezes 
11. PR=Pleural Rub 
12. RA=Rales 
13. RH=Rhonchi 
14. SIR=Sibilant Rhonchi 
15. SOR=Sonorous Rhonchi 
16. ST=Stridorous -(C) RUL Posterior [250018] 1. AB=Absent 
2. CL=Clear 
3. CR=Crackles 
4. CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 
9. EEW\=End Expiratory Wheezes 
10. IW=lnspiratory Wheezes 
11. PR=Pleural Rub 
12. RA=Rales 
13. RH=Rhonchi 
14. SIR=Sibilant Rhonchi 
15. SOR=Sonorous Rhonchi 
16. ST =Stridorous 
(C) LUL Posterior [25001 9] 1. AB=Absent 
2. CL=Clear 
3. CR=Crackles 
4. CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 
9. EEW=End Expiratory Wheezes 
10. I R=lnspiratory Wheezes 
11. PR=Pleural Rub 
12. RA=Rales 
13. RH=Rhonchi 
14. SIR=Sibilant Rhonchi 





(C) RML Posterior [250020] 1. AB=Absent 
2. CL=Clear 
3. CR=Crackles 
4. CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 
9. EEW=End Expiratory Wheezes 
10. IW=lnspiratory Wheezes 
11 . PR=Pleural Rub 
12. RA=Rales 
13. RH=Rhonchi 
14. SIR=Sibilant Rhonchi 
15. SOR=Sonorous Rhonchi 
16. ST=Stridorous 
(C) RLL Posterior [250021 ] 1. AB=Absent 
2. CL=Clear 
3. CR=Crackles 
4. CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 
9. EEW=End Expiratory Wheezes 
10. IW=lnspiratory Wheezes 
11 . PR=Pleural Rub 
12. RA=Rales 
13. RH=Rhonchi 
14. SIR=Sibilant Rhonchi 
15. SOR=Sonorous Rhonchi 
16. ST=Stridorous -
(C) LLL Posterior [250022] 1. AB=Absent 
2. CL=Clear 
3. CR=Crackles 
4. CO=Coarse Crackles 
5. F=Fine Crackles 
6. D=Diminished 
7. EG=Expiratory Grunting 
8. EW=Expiratory Wheezes 
9. EEW=End Expiratory Wheezes 
10. IW=lnspiratory Wheezes 
11 . PR=Pleural Rub 
12. RA=Rales 
13. RH=Rhonchi 
14. SIR=Sibilant Rhonchi 
15. SOR=Sonorous Rhonchi 
16. ST=Stridorous 
Cough [30472046] Cough [302590] 1. Congested 
2. Croupy 











11. Other (Comment) 
12. Not assessed 





6. Other (Comment) 
7. Not assessed 
(C) Sputum Color [302610) 1. Clear 




6. Pale yellow 





12. Other (Comment) 
13. Not assessed -(C) Sputum Consistency [302620) 1. Frothy 
2. Mucoid 





8. Other (Comment) 
9. Not assessed 





6. Nasal tracheal 
7. Oral 
8. Oral tracheal 
9. Spontaneous 
10. Tracheal 
11. Other (Comment) 





6. Other (Comment) 
7. Not assessed 
Sputum Color [302610) * 1. Clear 







6. Pale yellow 





12. Other (Comment) 
13. Not assessed 
Sputum Consistency [302620) * 1. Frothy 
2. Mucoid 





8. Other (Comment) 
9. Not assessed 





6. Nasal tracheal 
7. Oral 
8. Oral tracheal 
9. Spontaneous 
10. Tracheal 
11. Other (Comment) -
*SUCTION PROCEDURE [30472047) 1. Nasotracheal Suction 
2. Artificial Airway Suction 
3. lnline Suction of Art ificial A irway 
4. Nasal Airway Placement 
5. Oropharyngeal Suction 
6. Other (Comment) 
Baseline Activity Baseline Activity [304030110) 1. None 
[30403011] 2. Mild 
3. Moderate 
4. High 
5. Very High 
RC Home Regimen Medications Therapy [4569) 1. Yes 
[4568) 2. No 
3. Unable to assess 
Alveolar Recruitment [4570) 1. Yes 
2. No 
3. Unable to assess 
Mucus Clearance [4571] 1. Yes 
2. No 
3. Unable to assess -
Oxygen Therapy [4572] 1. Yes, Continuous 
2. Yes, at night 
3. Yes, with exertion 
4.No 
5. Unable to Assess 
6. Other (Comment) 









- ,...____ 7. Other (Comment) 
COPD Assessment Test How often do you cough? [10283] 1. O=Never Cough 




----- 6. 5=Cough all the time How often do you have 1. O=No phlegm 
phlegm/mucus in your chest? 2. 1=1 
[10285] 3. 2=2 
4.3=3 
5. 4=4 





6. 5=Very Tight 
When walking up hill or flight of 1. O=Not Breathless 




6. 5=Very Breathless 
How limited are you at home with 1. O=Not Limited 




----- 6. 5=Very Limited How confident are you in leaving 1. O=Very Confident 
home despite lung condition? 2. 1=1 
[10290] 3. 2=2 
4.3=3 
5. 4=4 





6. 5=1 don't sleep soundly 
How much energy do you have? 1. O=I have lots of energy 




6. 5=1 have no energy 




Spirometry Spirometry completed within 1 year 1. Yes 
Classification of COPD and available? [3040301 19] 2. No-admitted for COPD 
[30403012] 3. No-admitted for NON COPD 
Reason 
- 4. Other (Comment) 
% Predicted FEV1 [304030120] Numeric Type -
% Predicted FEV1 /FCV Ratio Numeric Type 
[304030121] 
Is the patients FEV1 /FVC ratio less 1. Yes 
than 0.70? [304030122] 2.No 
3. Other (Comment) 
(C) If the patients FEV1/FVC ratio is 1. Gold 1: Mild- FEV1 greater than or 
less than 0.70, SELECT ONE: equal to 80% predicted 
[304030123) 2. Gold 2: Moderate- FEV1 between 50-
80% 
3. Gold 3: Severe- FEV1 between 30-
50% predicted 
4. Gold 4: Very Severe- FEV1 less than 
30% predicted 
If the patients FEV1 /FVC ratio is less 1. Gold 1: Mi ld· FEV1 greater than or 
than 0.70, SELECT ONE: [304030123] equal to 80% pred icted 
* 2. Gold 2: Moderate- FEV1 between 
50-80% 
3. Gold 3: Severe- FEV1 between 30· 
50% predicted 
4. Gold 4: Very Severe- FEV1 less 
than 30% predicted 
COPD Exacerbations Hospitalization Admissions for COPD 1.0=0 
[30403013] within 1 year [304030130] 2. 1=1 
3.2=2 
4.3=3 -
Emergency department for COPD 1.0=0 
within 1 year [304030131] 2. 1=1 
3.2=2 
4.3=3 -
Primary Care for COPD wit hin 1 year 1.0=0 
[304030132] 2. 1=1 
3.2=2 
4.3=3 
Total Visits for COPD within 1 year Numeric Type 
[304030133] 
Patient Classification GOLD Guideline Patient 1. A • Low Risk/Less Symptoms, 
[3043001 OJ Classification [30430003] GOLD 1-2, Exa. 1 or <1 , CAT<10 
2. B • Low Risk/More Symptoms, 
GOLD 1-2, Exa. 1 or <1 , CAT 10 or 
>10 
3. C • High Risk/Less Symptoms, 
GOLD 3-4, Exa. 2 or >2, CAT<10 
4. D • High Risk/More Symptoms, 
GOLD 3-4, Exa. 2 or >2, CAT>10 
COPD Diagnostics lnspiratory Flow Rate Value Numeric Type 
[30403014] [304030140] 
* INSPIRATORY FLOW RATE 1. Yes 
COMPLETED [304030141] 2. Other (Comment) 




Assessment Score (On 2. 1- End Expiratory 
Scale of 1 to 4) Wheeze/Diminished 
[30403015) 3. 2- Pronounced Expiratory Wheeze 
4. 3- lnpiratory & Expiratory Wheeze 
5.4-Absentornearabsent 
Dyspnea (SOB) at Rest [304030151) 1. 0- None 
2. 1- Slight - Just Noticeable 
3. 2- Mild - Moderate 
4. 3 - Somewhat Severe 
,_____ 5. 4 - Very Severe - Maximal 
Bronchodilator Therapy Assessment Numeric Type 
Score [304030153) 
Pulmonary Rehab *PULMONARY REHAB PHASE ONE 1. Initial Assessment Completed 
Inpatient [30430004) [30430005) Phase One 
*RT COPD EDUCATION [9933) 1. 15 minutes 
2. 30 minutes 
3. 45 minutes 
4. 1 hour 
5. 1 hour 15 minutes 
6. 1 hour 30 minutes 
7. 1 hour 45 minutes 
8. 2 hours ,_____ 
Treatment and Procedure [30430006) 1. Medications 
2. Test I Procedures 
3. Pulmonary Rehab 
4. Spirometry 




9. Other (Comment) 
Self Care [30430007) 1. Breathing Retraining 
2. Energy Conservation Techniques 
,_____ 3. Other (Comment) -
Psychosocial I Spiritual [30430008) 1. Anxiety Reduction 
2. Coping Mechanisms 
3. Support Systems 
4. Spiritual I Emotional Needs 
5. Other (Comment) 
Prevention I Discharge [30430009) 1. Discuss signs I symptoms of 
COPD 
2. Discuss when to notify doctor 
3. Discuss medications w ith patient 
and/or family 
4. Discharge plan 
5. Discharge instruction 
6. Smoking cessation 
7. Flu vaccination 
8. Pneumonia vaccination 




- Start removed 
- Flowsheet Group/Row included in the template 













   
   
  
  




    
   
  
   
   
    
  
  
    
   
 
   
   






     
 
 
    
      
   
    
  
 
    
   




Caring for the Exacerbated Patient 
Nursing Education 
OBJECTIVES 
1. Define COPD and a COPD Exacerbation 
2. Identify prevalence, risk factors, and warning signs 
for exacerbation 
3. Define & discuss GOLD Guidelines 2014 
4. New Order Set: COPD Exacerbation 
5. Nursing documentation: PTA medications, order 
sets, care plan, patient education, discharge 
6. Identify post discharge care, community partners, 
Pulmonary Rehabilitation 
COPD PREVALENCE 
3rd Leading Cause of Death in America 
Affects 12 million Americans, another 12 million are 
said to be undiagnosed. 
Most (70%) of patients said to have COPD are under 
the age of 65. 
1 out of 4 hospitalized patients at TCH had a diagnosis 
of COPD in 2013, 24% of our patient population. 
DEFINITION 
In COPD, less air flows in and
out of the airways because of
one or more of the following: 
• The airways and air sacs 
lose their elastic quality. 
• The walls between many of
the air sacs are destroyed. 
• The walls of the airways 
become thick and 
inflamed. 
• The airways make more
mucus than usual, which 
can clog them. 
TWO RELATED DISEASES 
• COPD is frequently related to cigarette smoking and
mainly involves two related diseases -- chronic 
bronchitis and emphysema. 
• Both are frequently present and cause chronic 
obstruction of airflow obstruction of the lungs. The
obstruction is generally permanent and progresses 
(becomes worse) over time. 
DEFINITION-COPD EXACERBATION 
COPD Exacerbation: An exacerbation of COPD is
a sustained worsening of the patient's condition,
from the stable state and beyond normal day-to-
day variations that is acute in onset and may






      
   
 
    




    
   
  
 
    
   
  
  





     
   
 
    
     
   
 
      
    
       
   
 
 
   
     
    
  
  
    
 
COPD RISK FACTORS 
80% to 90% of COPD in the USA is attributed to a
current or past history of cigarette smoking 
Other causes/factors include: 
Air pollution 
Exposure to secondary cigarette smoke 
History of serious respiratory infections during childhood 
Genetics (including Alpha-1 antitrypsin  (AAT deficiency) 
Occupational exposures 
WHAT CAUSES EXACERBATIONS? 
Each person has different causes of exacerbation. 
Examples include: 
Smoking or being around smoke 
Infections, like colds or flu 
Strong fumes, like car exhaust or perfume 
Air pollution and smog 
Weather changes 
Very cold or very humid air 
PATIENT SYMPTOMS MAY INCLUDE: 
• A progressively worsening cough 
• Increased wheezing
• Increased shortness of breath beyond daily baseline 
• Coughing up more mucus 
• Change in mucus color (clear, white, yellow, green, 
gray, blood tinged) 
• Fever 
COPD ACTION PLAN FOR PATIENTS 
IMPACT OF EXACERBATIONS OF COPD 
Acute exacerbation care requirements range from unscheduled
primary care visits to emergency room, inpatient or intensive care, 
generating significant costs in COPD. 
Even after an exacerbation resolves, respiratory, physical, social
and emotional impairment may persist for prolonged time. 
Frequent exacerbations, mainly in patients with severe COPD, 
accelerate disease progression and mortality. 
Thus, patients with frequent exacerbations have a more rapid
decline in lung function, worse quality of life and decreased
exercise performance. 
Management of COPD directed to reduce incidence and severity of
exacerbations improves long-term health status and conserves
health care resources and costs. 
EXACERBATIONS = DISEASE ACCELERATION 
Repeated episodes of COPD exacerbations may
potentially impair lung tissues and lead to an
accelerated rate of decline in pulmonary function. 
Frequent exacerbations are associated with more rapid 
decline of FEV1 





    
      
   
  
   
 
    
   
     
  
  
     











   
 
   
   
  
  












   
   
  
      
     
    
 
   
   
  
   
IDENT IFIED GAPS IN CARE FOR COPD PATIENTS 
#1 Evidence Based/Guideline therapy not being
implemented. 
– GOLD Guidelines 2014 & Order set creation 
#2 Medication management issues.
– Guideline driven medication management at discharge 
#3 Patient education.
– Educational booklets & Action plan created 
#4 Under utilization of Pulmonary Rehabilitation Program 
- Increased education to physicians and patients in 
regards to pulmonary rehab referrals 
#1 GOLD GUIDELINES -2014 
The initiative started in 1997 and it’s guidelines are 
shaped by committees made up of leading experts from
around the world. 
• National Heart, Lung, and Blood Institute 
• National Institutes of Health, USA 
• World Health Organization 
#1 SPIROMETRY
• Spirometry is required to 
make a clinical diagnosis of
COPD 
• The presence of a post-
bronchodilator FEV1/FVC
<0.70 confirms the presence
of persistent airflow
limitation and thus COPD. 
• Simple Bedside PFT’s can
give us the FEV1 and this is
how we stage severity of
airflow limitation 
**We CANNOT perform 
spirometry when patients are 
in exacerbation. ** 
#3 RISK ASSESSMENT FOR EXACERBATION 
The best general definition of a COPD
exacerbation is the following:
• An exacerbation of COPD is a sustained worsening of the
patient's condition, from the stable state and beyond normal
day-to-day variations that is acute in onset and may warrant 
additional treatment in a patient with underlying COPD. 
• Assess risk, COPD exacerbations are considered any
worsening of symptoms, not necessarily hospitalizations. 
• Two categories according to GOLD Guidelines: 
< or = 1    or > or = 2 
#2 COPD ASSESSMENT TEST 
• Determine severity of  symptoms on patient’s 
health status through utilization of CAT tool
(right) 
CAT’s Usefulness: 
• Gives Clinicians a picture of their everyday
activities and baseline function. 
• The CAT Development Steering Group and the 
GOLD strategic document recommend that 
patients routinely complete the CAT
questionnaire every 2 to 3 months to detect 
changes and trends in CAT score. 
• We believe a change of 2 units suggests a     
meaningful difference. 
• Worsening scores may indicate that patients 
are experiencing exacerbations that they have 
not reported to you. 
• CAT scores may also worsen where a patient 
has stopped or is not taking their treatment 
effectively. 
3 STEP BREAKDOW N OF GOLD GUIDELINES 
#1 Spirometry 
#2 COPD Assessment Tool (CAT) 
#3 Exacerbation Risk Assessment 




    
   




   
 
    
   
   
  
    
 
   
   
 
     
    
 
    
  
      
   
  
  
    
   
       
   
    
    
      
 
4 PATIENT GROUPS FOR STAGING COPD 
Accurate staging, or knowing the severity of 
your COPD, could have various benefits, such 
as: 
• Helping people with COPD understand their disease 
better 
• Helping doctors make better treatment 
recommendations for people with COPD 
• Helping people with COPD plan for their future, and 
predict life expectancy 
A B C D 
4 PATIENT GROUPS FOR STAGING COPD -
RECOMMENDATIONS 
• All patients with COPD who smoke
should be counseled about smoking
cessation. 
• Influenza and pneumococcal 
vaccinations are recommended for all
patients with COPD. 
• Pulmonary rehabilitation is
recommended for patients in groups B, 
C, and D. 
THE CHRIST HOSPITAL GOLD GUIDELINE
MEDICATION RECOMMENDATION, BASED ON TCH 
INPATIENT PHARMACY 
#1 COPD EXACERBATION –NEW ORDER SET
AVAILABLE OCTOBER - 2014 
WHO SHOULD GET THE ORDER SETS?
• Any patient in with a primary diagnosis
COPD Exacerbation should have the
COPD Exacerbation Order Set 
(#2076) added to their orders. 
• Contact the MD for permission to add
Order Set. 
# 2 RESPIRATORY MEDICATION AND THE
MANAGEMENT OF THE COPD PATIENT 
We need the patient’s to stay on their maintenance
medications for COPD in particular. 
This helps to reduce future exacerbations and ensures 
their medication will continue on discharge. 
If the patient has brought in their medications, please
place an order for home medications and place the







       
   
  
  
    
 
  
     
  
 
     
   
   
 
   
  
  
     
 
 
   
   
    
   
       
   










   
    
MEDICATION-MAINTENANCE VS . RESCUE 
• If a patient has a chronic lung condition, daily
“maintenance” or “controller” medicines are
usually needed.
• These last longer and provide a more steady,
even delivery of medicine over a longer
period of time. Maintenance medicines keep 
day-to-day symptoms under control. 
• Medicines that are needed only at times are 
called “rescue” or “as-needed” medicines. 
RESPIRATORY MEDICATIONS AND COPD 
None of the current medications for COPD has been
shown to stop the long-term decline in lung function.
However, there are several types of medications used
to control symptoms. 
• Bronchodilators -- increase airflow by opening airways 
and making it easier to breathe 
• Corticosteroids -- reduce inflammation; either inhaled
with an inhaler or taken by mouth, they are usually used 
to treat moderate to severe COPD 
• Leukotriene modifiers -- help prevent inflammation and 
swelling in airways, and reduce mucus 
• Antibiotics -- used to treat respiratory infections 
• Combination therapy -- taking inhaled corticosteroids 
and bronchodilators together is an effective treatment in 
stable COPD 
MAINTENANCE MEDICATION THE ORDER SETS GENERATE A NURSING  






HERE IS THE PDF LINK 





inhalers the patient takes 
at home, some patients do
not think of inhalers as 
medications. 
Show a picture of
medications, if necessary
or if prior to admission
medications states 
inhalers 






    
 
   
  
  
    
    




    
 
  











      
 
 
# 3 PATIENT EDUCATION 
Patient education will consist of the following materials: 
COPD handbook 
Breath Easier handbook 
Action Plan Rip Off Sheet 
Action Plan Magnet 
Pulmonary Rehabilitation flyer & locations 
COPD RT staff will go through educational flip book 
with patient and family, if applicable.
All items are available for order through Workflow One
Website.
COPD HANDBOOKS 
COPD EDUCATIONAL FLIP BOOK COPD ACTION PLANS 
PULMONARY REHABILITATION 
If patient is B,C,D they need to be
considered for an Out-patient 
Pulmonary Rehabilitation Referral 
We will give the patient options
with Pulmonary Rehab programs
available in the city, but we do
have a flier for ours. 
We are located in the MOB, Suite 
224, our number is 585-2787 for 
any questions or concerns. 







No changes have been made to the care plan. The RT
COPD Navigator/Educator will begin documenting here, 










    
     
    
 
   
   







   
 




   
 
   
    
   
 
 
   
   
   
 
 
     
  
  
     
   




   
   
     
   




   
 
    
DOCUMENTATION: PATIENT EDUCATION 
No changes have
been made to the





along with nursing. 
COPD NAVIGATOR/EDUCATOR DISCHARGE 
PLANNING DUTIES 
• Discuss and set discharge goals with patient
and family. 
• Set up follow up appointments, if applicable 
• Assist Social Work and Case Management in 
arranging home health, outpatient therapy, or
long term care placement. 
• Obtain respiratory equipment if needed. 
• Provide instructions and handouts in folder. 
• Assist with community resources and support
groups. 
# 4 BENEFITS OF PULMONARY REHABILITATION 
• Improve the patient’s quality of life 
• Help the patient function better in daily life 
• Increase the patient’s ability to exercise 
•	 Decrease the symptoms of the patient’s disease or
condition 
• Helps to manage anxiety and depression 
•	 The patient also may have fewer breathing 

problems as a result of PR. Although PR doesn't
 
improve your lung function, it allows you to make
 
the most of the limited lung function you have
 
• A reduction in COPD admissions and readmissions 
DOCUMENTATION BY COPD NAVIGATOR EDUCATOR 
WILL BE UNDER CONSULTS 
•	 Navigator will be putting in recommendations under 
the consult tab of notes. 
•	 Patient’s disease severity classification will be
documented in this area and recommendations for 
pharmacological and non-pharmacological 
management.
•	 If patient’s are admitted for a COPD exacerbation, 
they need to be discharged with maintenance
medications according to their GOLD Guideline
Patient Classification (A,B,C,D). 
COPD COMMUNITY COLLABORATIVE 
•	 We have multiple community partners in all levels of
care for the COPD patient.
•	 Our partners include: Home Care, Senior Nursing
Facilities, Acute Rehab, Hospice, Assisted Living
Communities, TCHMA Primary Care Offices, TCHHN
Pulmonary Rehabilitation Clinic, and Tri-State
Pulmonary Associates. 
•	 The patient will receive additional education and 
reinforcement on self management. 
•	 Social Work and Case Management have the list of
community partners who will assist us preventing
readmissions. 
HOW WILL YOUR PRACTICE BE IMPACTED?
•	 Nursing communication is triggered by order set 
placement to assist in identification of prior to
admission respiratory medications. 




•	 Collaborate with Respiratory to achieve optimal 
patient care. 
•	 Assist in disseminating discharge recommendations 




   
  
  
   
     
  
      
  
           
        
 
         
           
    
           
 
          
  
 
        
    










If you want to go fast, go alone…. 
If you want to go far, go together… 
African Proverb Quote 
Together we can treat our COPD patients appropriately
and efficiently based on a multi-dimentional evidence
based embedded practice 
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n Enc Start Enc End Attending 
Proj Wk1 no no 11/5/2014 11/7/2014 
Proj Wk2 no no 11/7/2014 11/13/2014 
Proj Wk2 YES YES 11/9/2014 11/13/2014 
Proj Wk4 no no 11/9/2014 11/26/2014 
Proj Wk2 YES no 11/10/2014 11/14/2014 
Proj Wk2 no no 11/10/2014 11/13/2014 
Proj Wk2 no no 11/11/2014 11/15/2014 
Proj Wk3 no no 11/13/2014 11/18/2014 
Proj Wk3 no no 11/16/2014 11/18/2014 
Proj Wk3 no no 11/18/2014 11/21/2014 
Proj Wk3 YES YES 11/18/2014 11/21/2014 
Proj Wk3 YES YES 11/19/2014 11/22/2014 
Proj Wk5 YES YES 11/22/2014 12/5/2014 
Proj Wk5 YES YES 11/23/2014 12/5/2014 
Proj Wk4 YES no 11/23/2014 11/29/2014 
Proj Wk4 no no 11/23/2014 11/29/2014 
Proj Wk4 no YES 11/23/2014 11/27/2014 
Proj Wk4 YES YES 11/23/2014 11/26/2014 
Proj Wk4 no no 11/24/2014 11/28/2014 
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